Download Oct 31, 2014 Nena Matijevic, PhD Page 1 CURRICULUM VITAE

Oct 31, 2014
CURRICULUM VITAE
NAME:
Nena Matijevic, Ph.D., Pharm.D., M.S., C.L.S.
PRESENT TITLE:
Professor
Department of Surgery and Center for Translational Injury Research
ADDRESS:
The University of Texas
Medical School at Houston
Department of Surgery
6431 Fannin, MSB 5.240
Houston, Texas 77030-1503
Telephone: (713) 500-6807
Fax: (713) 500-0685
Email: [email protected]
CITIZENSHIP:
U.S.A.
UNDERGRADUATE EDUCATION:
1974
Pharm.D.
University of Belgrade, Faculty of Pharmacy, Belgrade, Yugoslavia
GRADUATE EDUCATION:
1986
M.S. in Medical Sciences – Hematology.
University of Belgrade, Medical School, Belgrade, Yugoslavia.
Thesis:“Platelet functions in patients with idiopathic
thrombocytopenic purpura (ITP).”
POSTGRADUATE TRAINING:
1988
Specialist in Medical Biochemistry (Clinical Chemistry, CLS)
University of Belgrade, Faculty of Pharmacy, Belgrade, Yugoslavia
Thesis: “Protein C activity in patients on oral anticoagulant therapy.
DOCTORAL STUDIES:
1998
Nena Matijevic, PhD
Ph.D. in Medical Sciences – Hematology
University of Belgrade, Medical School, Belgrade, Yugoslavia.
Dissertation: “Expression of prostaglandin H2 synthase and
thromboxane A2 synthase in megakaryocytes and platelets”
Page 1
ACADEMIC APPOINTMENTS:
1974 – 1975
Regular Pharmaceutical Practice, Belgrade City Hospital Pharmacy,
Belgrade, Yugoslavia
1975 – 1976
Central Clinical Chemistry Laboratory, Belgrade City Hospital,
Belgrade, Yugoslavia
1976 – 1988
Hemostasis Laboratory Manager, Belgrade City Hospital, Belgrade,
Yugoslavia
1988 – 1992
Hemostasis Laboratory Director, University Clinical Center,
Department of Hematology, Belgrade, Yugoslavia
1992 – 2000
Research Instructor, University of Texas Houston Health Science
Center, Medical School, Internal Medicine, Hematology and Vascular
Biology Research Center, Houston, Texas
1996 – 2008
ARIC (Atherosclerosis Risk in Communities) Central Hemostasis
Laboratory Director, University of Texas, Medical School, Internal
Medicine, Hematology, Houston, Texas
2000 – 2007
Assistant Professor in Medicine, University of Texas, Medical
School, Internal Medicine, Hematology and Vascular Biology
Research Center, Houston, Texas
2001 – 2008
Flow Cytometry Laboratory Director, University of Texas, Medical
School, Internal Medicine, Hematology and Vascular Biology,
Houston, Texas
2007 – 2008
Associate Professor in Medicine (Research, NT), University of Texas,
Medical School, Internal Medicine, Hematology, Houston, Texas
2008 – Present
Flow Cytometry Laboratory Director, University of Texas, Medical
School, Department of Surgery, Houston, Texas
2008 – 2013
Associate Professor (Research, NT), University of Texas, Medical
School, Department of Surgery and Center for Translational Injury
Research, Houston, Texas
2008 – Present
Hemostasis Laboratory Director, University of Texas, Medical
School, Department of Surgery and Center for Translational Injury
Research, Houston, Texas
Nena Matijevic, PhD
Page 2
2013 – Present
Professor (Research, NT), University of Texas, Medical School,
Department of Surgery and Center for Translational Injury Research,
Houston, Texas
PROFESSIONAL ORGANIZATIONS/SOCIETY MEMBERSHIPS:
2012 - Present
The North American Society on Thrombosis and Hemostasis
1999 – Present
American Society of Hematology
2000 – Present
International Society on Thrombosis and Haemostasis
2006 – 2008
International Clinical Cytometry Society
2006 – 2009
Mediterranean League against Thromboembolic Disease
SCIENTIFIC JOURNAL REVIEWER:
Circulation
Journal of Thrombosis and Hemostasis
Journal of Neurology
Transfusion
Thrombosis Research
ARIC (Atherosclerosis Risk in Communities) Study Publications
CHS (Cardiovascular Health Study) Publications
ARIC Carotid MRI Study Publications
SERVICE ON NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS,
COMMITTEES:
1996 – 2005
Nena Matijevic, PhD
Laboratory Committee, ARIC Study, NIH/National Heart Lung and
Blood Institute
Page 3
2004 – 2008
Laboratory Committee, ARIC Carotid MRI Study, NIH/National
Heart Lung and Blood Institute
2004 – 2008
Quality Control Committee, ARIC Carotid MRI Study, NIH/National
Heart Lung and Blood Institute
2008 – 2010
PROMMTT (Prospective Observational Multicenter Massive
Transfusion sTudy) Laboratory Committee, US Department of
Defense
2009 – Present
PROPPR (Pragmatic Randomized Optimal Platelet and Plasma
Ratios) Study Laboratory Committee, NIH/NHLBI
THE UNIVERSITY OF TEXAS MEDICAL SCHOOL COMMITTEES/ACTIVITIES:
2011 – Present
Faculty Senate
2011 – Present
Committee on Committees
2011 – Present
Medical Student Interviewer
CURRENT GRANT SUPPORT:
2010 – 2014
Co-Investigator
PI: Suzanne May, PhD
NIH/NHLBI via ROC (5U01HL077863)
Title: Pragmatic, Randomized Optimal Platelet and Plasma Ratios
(PROPPR)
$50,088,890
GRANTS PENDING:
2014 – 2018
Nena Matijevic, PhD
Co-Investigator
PI: Marie Francoise Doursout, PhD
NHLBI
Title: Impact of Microparticle Pro-Inflammatory and Pro-Coagulant
Properties on Sepsis-Induced Endothelium Dysfunction.
$1,440,936
Page 4
PAST GRANT SUPPORT:
1992 – 2006
Co-Investigator
PI: Kenneth K Wu, MD
NIH/NHLBI, N01
Title: Atherosclerosis Risk in Communities (ARIC) Study:
Morbidity/Mortality Follow-up: Central Hemostasis Laboratory
1998 - 2002
Co-Investigator
PI: Aaron Folsom, MD,
UMNSPH, NIH/NHLBI, R01
Title: Longitudinal Investigation of Thromboembolism Etiology
(LITE).
1999 – 2004
Co-Investigator, Core Lab
Principal Investigator: Kenneth K Wu, MD, PhD
NIH/NHLBI, P50
Title: Prostaglandins in Cerebral Vascular Thrombosis.
2004 – 2009
Co-investigator; PI for cellular studies
PI: Eric Boerwinkle, PhD
NIH/NHLBI (5U01HL075572)
Title: Atherosclerosis, Plaque and CVD in Communities
$1,404,859
2009 – 2010
Co-Investigator
PI: Jodie Conyers, PhD
US Department of Defense, USAMRMC (W81XWH-07-2-0031)
Title: Texas Science, Humanitarian Intervention, Education and
Leadership in Disaster (TexSHIELD)
$1,286,794
2009 – 2010
Co-Investigator
PI: John B Holcomb, MD
US Department of Defense
Title: Early Whole Blood for Patients Requiring Massive Transfusion
after Major Trauma
2010 – 2011
Co-investigator
PI: Mohammad Hossein Rahbar, PhD
US Department of Defense, USAMRMC (W81XWH-08-C-0712)
Title: Coagulation Abnormalities in Severely Injured Patients
(PROMMTT- Modification)
$1,000,000
Nena Matijevic, PhD
Page 5
2011 – 2012
2009 – 2013
Co-Investigator
PI: Charles E Wade, PhD
US Department of Defense, USAMRMC (W81XWH-11-1-0023)
Title: Characterization and Application of a Large Model of
Penetrating Ballistic Brain Injury
$1,267,646
Co-investigator
PI: Mohammad Hossein Rahbar, PhD
US Department of Defense, USAMRMC (W81XWH-08-C-0712)
Title: Prospective, Observational, Multicenter Major Trauma
Transfusion study (PROMMTT)
$10,031,550
PUBLICATIONS:
A. ABSTRACTS
1.
Pendic B, Matijevic N, Plecas V, Dragovic M. Effects of cytostatics commonly used for
treatment of acute leukemia on platelet aggregation in vitro. 6th Meeting of Yugoslav
Society of Hematology and Transfusiology, Portoroz. Abstract book. 1976.
2.
Matijevic N, Pendic B, Zdravkovic M, Ivankovic D. The effect of aspirin on platelet
aggregation in vivo and in vitro. VII Yugoslav Congress of Pharmacy, Ohrid, Abstracts.
p.80. 1976.
3.
Matijevic N, Sisic I, Korolija P, Pendic B. Estimation of hemostasis in elderly subjects
treated with Complamin®. I Yugoslav Congress of Gerontologists, Belgrade, Abstract book.
1977.
4.
Zdravkovic M, Matijevic N, Ivankovic D, Pendic B, Tubin M, Cvetkovic G. Platelet
aggregation and gastrointestinal complications during the treatment of rheumatic fever with
aspirin. XV Meeting of Internists, Symposium "Drugs and Health", Subotica. Abstract book.
1977.
5.
Matijevic-Aleksic N, Pajevic M, Milutinovic Dj, Tomasevic R, Pendic B. The influence of
platelet storage and temperature on platelet functions. III Yugoslav Congress of Hematology
and Transfusiology, Sarajevo, 1978. Abstracts, p.153-154.
6.
Jelic S, Bojic M, Dragovic M, Miletic V, Matijevic N, Plecas V. Leukemic phase of diffuse
histiocytic lymphoma (Reticulum Cell Sarcoma). III Yugoslav Congress of Hematology and
Transfusiology, Sarajevo. Abstracts, p.123-124. 1978.
7.
Pajevic M, Matijevic N, Jelic S, Djuric D, Pendic B, Plecas V. Investigation of
immunological and hemostatic parameters related to platelets transfusion in patients with
Nena Matijevic, PhD
Page 6
malignant hemopathies. III Yugoslav Congress of Hematology and Transfusiology,
Sarajevo. Abstracts, p.151-152. 1978.
8.
Miletic V, Jelic S, Gligorovic V, Matijevic N, Plecas V. Physicochemical properties and
biologic effects of commercial gamma globulin preparations. III Yugoslav Congress of
Hematology and Transfusiology, Sarajevo. Abstracts p.159-160. 1978.
9.
Pendic B, Matijevic N. Cytostatics and platelet aggregation. III Yugoslav Congress of
Hematology and Transfusiology, Sarajevo. Abstracts, p.230-231. 1978.
10.
Savic S, Zdravkovic M, Najdanovic B, Ivankovic D, Ristic V, Madic R, Dimitrijevic I,
Djordjevic G, Matijevic N. Les effets du Propranolol (Inderal) sur l' hypertension arterielle
chez les malades avec des valeurs elevees de l' activite de la renine plasmatique. VII
Congress International de Pharmacologie, Paris, France, 1978.
11.
Savic S, Zdravkovic M, Najdanovic B, Ivankovic D, Djordjevic G, Matijevic N. The
activity of plasma rennin and aldosterone in the essential hypertension and the effects of
Propranolol on the former. International Symposium on Essential Hypertension, Herceg
Novi, 1978.
12.
Matijevic N, Miletic V, Pendic B. Characteristics of platelet aggregation induced by heataggregated immunoglobulins. VI Yugoslav Symposium of Immunology, Tara, 1979.
13.
Matijevic N, Miletic V, Pendic B. Aggregation of human blood platelets with monomeric
and aggregated immunoglobulins. II Meeting of Yugoslav Society of Hemostasis and
Thrombosis, Belgrade, 1979.
14.
Jelic S, Matijevic N, Miletic V. Platelet aggregation in vitro in the presence of mixed IgG
and IgM cryoglobulins. II Meeting of Yugoslav Society of Hemostasis and Thrombosis,
Belgrade, 1979.
15.
Matijevic N, Petrovic M, Vidakovic B, Plecas V, Pendic B. Platelet function in cytostatics
treated patients. VII Meeting of Yugoslav Society of Hematology and Blood Transfusion,
Split, 1980.
16.
Pendic B, Matijevic N, Dimitrijevic B, Pantic V. Action des agents da la chimiotherapie sur
l’ aggregation plaquettaires in vitro. 18th International Congress of the Society of
Hematology, Montreal, Canada. Abstract 1197, 1980.
17.
Milenkovic Lj, Tomasevic R, Djuric D, Radovic M, Matijevic N. Comment on certain
platelet preparation procedures for transfusion. Symposium "Current problems in health care
of hematologic patients", Belgrade, 1980.
18.
Matijevic-Aleksic N, Pendic B. Clinical use of platelet aggregation studies. VI Yugoslav
Congress of Clinical Chemistry, Split, 1983.
Nena Matijevic, PhD
Page 7
19.
20.
Pudar-Brankovic G, Matijevic-Aleksic N, Peric Lj, Mijalkovic D, Brankovic S. Platelet
aggregation in patients with diabetes mellitus. Yugoslav Congress of Endocrinology, Novi
Sad, 1984.
Matijevic-Aleksic N, Rolovic Z, Pendic B. Platelet function in patients with idiopathic
thrombocytopenic purpura. IV Yugoslav Congress of Hematology and Transfusiology,
Skoplje, 1984.
21.
Despotovic N, Paranos S, Matijevic-Aleksic N, Rosic D. Platelet aggregation abnormalities
in patients with elevated IgE. Scientific Meeting of Serbian Academy of Sciences and Art,
Division of Medical Sciences, "Specific Hypersensitivity of the Organism", Belgrade.
Abstract book.1986.
22.
Matijevic-Aleksic N, Petrovic M, Rajic M,Vidakovic B. Antithrombin III in patients with
malignant hemopathies. V Yugoslav Congress of Hematology and Transfusiology, Maribor.
Abstracts. 1986.
23.
Matijevic-Aleksic N, Rolovic Z. Platelet aggregation in patients with idiopathic
thrombocytopenic purpura. V Yugoslav Symposium on Hemostasis and Thrombosis, Novi
Sad. Abstract book. 1987.
24.
Matijevic-Aleksic N, Jovic B, Paranos S, Despotovic N. Influence of elevated
concentrations of serum IgE on human platelet aggregation. 7th Yugoslav Congress of
Clinical Chemistry, Novi Sad. Abstract book.1987.
25.
Matijevic-Aleksic N, Petrovic M, Jovic B, Rajic M, Vidakovic B. Hemostasis inhibitors in
patients with malignant hemopathies. VII Yugoslav Congress of Cancer, Novi Sad. Abstract
book. 1987.
26.
Petrovic M, Matijevic-Aleksic N, Plecas V, Radulovic S. Hemostasis abnormalities in
malignant diseases. XXIV Meeting of Oncology and Radiology, Belgrade, 1987.
27.
Matijevic-Aleksic N, Jelic Z, Majkic-Singh N. Protein C and oral anticoagulant therapy. II
Dalmatian Meeting of Clinical Chemistry, Split. Abstract book. 1988.
28.
Starcevic D, Matijevic-Aleksic N, Jelic-Ivanovic Z. C1-esterase inactivator in malignant
diseases. II Dalmatian Meeting of Clinical Chemistry, Split. Abstract book. 1988.
29.
Matijevic-Aleksic N, Petrovic M, Plecas V, Vidakovic B, Panajotovic-Jovic B. Comparison
of hemostatic parameters in patients with malignant diseases. IX Meeting of Yugoslav
Society of Hematology and Transfusiology, Novi Sad. Abstracts. 1988.
30.
Matijevic N, Elezovic I, Rolovic Z. Plasma levels of thrombin-antithrombin (TAT) complex
in patients with acute leukemia. VI Yugoslav Meeting of Society of Hemostasis and
Thrombosis, Ljubljana. Abstracts. 1990.
Nena Matijevic, PhD
Page 8
31.
Matijevic N, Elezovic I, Rolovic Z. Plasma levels of fibrinogen and fibrin degradation
products in patients with acute leukemia. VI Yugoslav Meeting of Society of Hemostasis
and Thrombosis, Ljubljana. Abstracts. 1990.
32.
Elezovic I, Matijevic N, Rolovic Z. Plasma levels and activities of factor XIII in patients
wuth acute leukemia. VI Yugoslav Meeting of Society of Hemostasis and Thrombosis,
Ljubljana. Abstracts. 1990.
33.
Matijevic-Aleksic N, Boskovic D, Rolovic Z. Control of oral anticoagulant therapy using
two different thromboplastins. 11th International Congress on Thrombosis, Ljubljana.
Abstracts.1990.
34.
Matijevic-Aleksic N, Jelic-Ivanovic. Functional assay of Protein C in patients on oral
anticoagulant therapy. 11th International Congress on Thrombosis, Ljubljana.
Abstracts.1990.
35.
Matijevic-Aleksic N, Elezovic I, Marisavljevic D, Colovic M, Rolovic Z. Thrombinantithrombin III complex in acute leukemia. 6th Yugoslav Congress of Hematology and
Transfusiology, Zagreb. Bilten Hematol Transf 17:110, 1990
36.
Elezovic I, Matijevic N, Boskovic D, Mijovic A, Tomin D, Colovic M, Novak A, Rolovic
Z. Disseminated intravascular coagulation in patients with acute promyelocytic leukemia.
6th Yugoslav Congress of Hematology and Transfusiology, Zagreb, 1990, Bilten Hematol
Transf 17:109, 1990
37.
Matijevic-Aleksic N, Elezovic I, Rolovic Z, Dimcic Z, Stefanovic Lj. Laboratory
manifestation of a lupus-like anticoagulant: case report. VIII Yugoslav Scientific Meeting of
Alergology and Clinical Immunology, Kopaonik. Abstracts. 1990.
38.
Matijevic-Aleksic N, Dimcic Z, Rolovic Z. Protein C and Protein S in systemic diseases.
VIII Yugoslav Scientific Meeting of Alergology and Clinical Immunology, Kopaonik.
Abstracts. 1990.
39.
Elezovic I, Matijevic-Aleksic N, Jancic A., Markovic Lj., Bonaci-Nikolic B., Djordjevic S.
Anticardiolipin antibodies in patients with immune thrombocytopenic purpura. VIII
Yugoslav Scientific Meeting of Alergology and Clinical Immunology, Kopaonik. Abstracts.
1990.
40.
Dimcic Z, Bukulica M, Djordjevic S, Matijevic-Aleksic N, Markovic Lj, Tanurdcic S,
Djuric M. Hemostatic abnormalities in patients with systemic lupus erythematosus
associated with a presence of anticardiolipin antibodies. VIII Yugoslav Scientific Meeting of
Alergology and Clinical Immunology, Kopaonik. Abstracts. 1990.
41.
Dimcic Z, Bonaci-Nikolic B, Markovic Lj, Matijevic-Aleksic N, Balaban J, Tanurdcic. A
case of cerebral systemic lupus erythematosus associated with anticardiolipin antibodies.
Nena Matijevic, PhD
Page 9
VIII Yugoslav Scientific Meeting of Alergology and Clinical Immunology, Kopaonik.
Abstracts. 1990.
42.
Elezovic I, Matijevic-Aleksic N, Marisavljevic D, Suvajdic N, Rolovic Z. Fibrinolysis and
fibrinogenolysis in acute leukemia. XIIIth Congress of the International Society on
Thrombosis and Haemostasis, Amsterdam. Thromb Haemostas 65:895. 1991.
43.
Matijevic-Aleksic N, Elezovic I, Suvajdic N, Rolovic Z. Levels of fibrinopeptide A and
thrombin-antithrombin III complex in patients with acute leukemia. XIIIth Congress of the
International Society on Thrombosis and Haemostasis, Amsterdam. Thromb Haemostas
65:1322. 1991.
44.
Matijevic-Aleksic N, Dulic B, Rolovic Z. Markers of hemostasis activation after total hip
replacement. 12th International Congress on Thrombosis, Florence, Italy. Abstracts
P353.1992.
45.
Simic N, Avramovic D, Matijevic-Aleksic N, Stevic S, Kalimanovska-Ostric D. Indobufen
treatment of angina pectoris: effects on platelet aggregation. International meeting in
Cardiology, Amsterdam.Abstracts.1992.
46.
Aleksic, N. M., Sanduja, S. K., Long, C., Wu, K. K. Coordinate expression of prostaglandin
H synthase and thromboxane A synthase in phorbol-induced differentiation of a
megakaryocyte cell line (MEG-01). 35th Annual Meeting, The American Society of
Hematology, St. Louis, MO, December 3-7. Blood, 82:suppl.1. 266. 1993.
47.
Wu, K.K., Sanduja, S.K, Tsai, A.-L., and Matijevic-Aleksic, N. Quantitative analysis of
prostaglandin H synthase (PGHS-1) decay in cells overxpressing PGHS-1. 9th International
Conference on Prostaglandins and Related Compounds, Florence, Italy, June 6-10. Abstract,
p.76.1994.
48.
Elezovic, I., Matijevic-Aleksic, N., Boskovic, D., Colovic, M., Mijovic, A.S., Tomin, D.,
Mijovic, A.M., Suvajdic, N., Vidovic, A., Rolovic, Z. Disorders of hemostasis in acute
leukemia. 1st Yugoslav Hematology Congress, Belgrade, Yugoslavia, October 1994. Bilten
Hematol 22:86, 1994.
49.
Elezovic, I., Matijevic-Aleksic, N.,Colovic, M.,. Boskovic, D., Mijovic, A.S., Tomin, D.,
A.M. Mijovic, Suvajdic, N., Maric, A., Rolovic, Z. Disseminated intravascular coagulation
in acute leukemia. 1st Yugoslav Hematology Congress, Belgrade, Yugoslavia, October
1994. Bilten Hematol 22:87.1994.
50.
Matijevic-Aleksic, N., Ghaddar, H., McPhedran, P., Wu, K.K. Bleeding disorder due to
platelet cyclooxygenase-1 (COX-1) deficiency. 36th Annual Meeting, American Society of
Hematology, Decembar 2-6, 1994, Nashville, TN. Blood. 84:suppl.1. 1267.1994.
51.
Elezovic, I., Matijevic-Aleksic, N
-1 proteinase inhibitor complexes
in acute leukemia. XV Congress of the International Society on Thrombosis and
Nena Matijevic, PhD
Page 10
Haemostasis, Jerusalem, Israel, June 11-16, 1995. Thromb Haemost 73:1146. 1995.
52.
Matei, M.C., Aleksic, N., Ahn, C., Wu, K.K., Juneja, H.S. Hemostasis activation markers in
sickle cell disease: association with painful crisis. 38th Annual American Society of
Hematology Meeting, Orlando, Florida, December 6-10, 1996. Blood. 88: suppl 1;2803.
53.
Elezovic, I., Pilic, Z., Nedeljkovic, N., Marisavljevic, D., Matijevic-Aleksic, N., Miljic, P.,
Radosevic, N., and Todorovic-Tirnanic, M.: Caesare section in a case with Bernard-Suilier
syndrome. X Yugoslav Hematology Days with International Participation, Niska Banja,
October 10-12, 1996. Abstract Book. 122. 1996.
54.
Elezovic I, Matijevic-Aleksic N, Rolovic Z: The role of elastase in coagulation disorders of
acute leukemia patients. X Yugoslav Hematology Days with International Participation,
Niska Banja, October 10-12, 1996. Abstract Book. 125.1996.
55.
Ghaddar, H.M., Aleksic, N., Hearne, L.B., Folsom, A.R., Chambless, L.E., Morrissey, J.H.,
Wu, K.K. The ARIC postprandial study: relation of factor VII with factor VII gene
polymorphism and triglyceride levels in carotid atherosclerosis cases and controls. XVIth
Congress of the International Society on Thrombosis and Haemostasis, Florence, June 6-12,
1997. Thromb Haemost Suppl, 413.1997.
56.
Folsom, A.R., Rosamond, W.D., Shahar, E., Cooper, L.S., Aleksic, N., Nieto, F.J.,
Rasmussen, M., Wu, K.K. Prospective study of markers of hemostatic function,
inflammation, and endothelial function with risk of ischemic stroke. Abstract 1072. 71st
Scientific Session of the American Heart Association, November 8-11, 1998, Dallas, Texas.
Circulation, Suppl I, 98:17:207.1998.
57.
Salomaa, V., Matei, V., Aleksic, N., Sansores-Garcia, L., Folsom, A.R., Juneja, H.,
Chambless, L.E., Wu, K.K. Soluble thrombomodulin as a predictor of incident coronary
heart disease: The ARIC study. Abstract 2756. 71st Scientific Session of the American Heart
Association, November 8-11, 1998, Dallas, Texas. Circulation. Suppl I, 98:17:524. 1998.
58.
Aleksic, N., Juneja, H., Folsom, A.R., Ahn, C., Boerwinkle, E., Chambless, W., Wu, K.K.
Prospective study of platelet PlA1/A2 polymorphism, platelet activation and incidence of
coronary heart disease. The 40th American Society of Hematology Annual Meeting, Miami
Beach, Florida, December 4-8, 1998. Blood 92 (suppl 1): 304a, 1998
59.
Wu KK, Aleksic N, Ahn C, Boerwinkle E, Folsom A, Juneja H. Association of
thrombomodulin 455A/V dimorphism with risk of developing coronary heart disease.
XVIIth Congress of the International Society on Thrombosis and Haemostasis, Washington
DC, Aug 14-21 1999. Thromb Haemost Suppl. 538.1999.
60.
Aleksic N, Ahn C, Boerwinkle E, Juneja H, Folsom AR, Wu KK. Factor XIII V34L
polymorphism and the risk for development of coronary heart disease. XVIIth Congress of
the International Society on Thrombosis and Haemostasis, Washington DC, Aug 14-21
1999. Thromb Haemost Suppl. 538.1999.
Nena Matijevic, PhD
Page 11
61.
Afshar-Kharghan V, Aleksic N, Ahn C, Boerwinkle E, Wu KK, Lopez JA. Prospective
study of the association of the variable number of tandem repeats (VNTR) polymorphism in
the International Society on Thrombosis and Haemostasis, Washington DC, Aug 14-21
1999. Thromb Haemost Suppl. 538.1999.
62.
Wu KK, Matijevic-Aleksic N, Ahn C, Boerwinkle E, Folsom AR, Juneja H.
Thrombomodulin 455A/V dimorphism is a risk factor for developing coronary heart disease
in African Americans but not in Caucasians: The ARIC Study. The 41th American Society
of Hematology Annual Meeting, New Orleans, Louisiana, December 3-7, 1999. Blood.
94:374.suppl.1.1999.
63.
Folsom AR, Aleksic N, Salomaa V, Park E, Juneja H, Wu KK. Fibrinolytic variables and
incident CHD in the Atherosclerosis Risk in Communities (ARIC) Study. 40th Annual
Conference on Cardiovascular Disease Epidemiology and Prevention, San Diego, CA,
March 1-4, 2000.Circulation. 101:721. 2000.
64.
Elezovic I, Matijevic-Aleksic N, Rolovic Z, Boskovic D, Colovic M. Hypercoagulability in
patients with acute leukemia prior to therapy. 28th Congress of the International Society of
Hematology, Aug 26-30, Toronto, Canada. Abstracts. 2000.
65.
Aleksic N, Ahn C, Juneja H, Boerwinkle E, Ballantyne CM, Wu KK. Effect of interaction of
plasma soluble thrombomodulin (sTM) and soluble intercellular adhesion molecule-1
(sICAM-1) on predicting risk of incident coronary heart disease (CHD): The ARIC Study.
The 42nd American Society of Hematology Meeting, San Francisco, CA, December 1-5,
2000. Blood. 96:11:816a.2000.
66.
Tumbusch KJ, Goldsby J, Arbab F, Matijevic-Aleksic N, Huang J-C. The expression of
prostaglandin H synthase-2 and the profile of arachidonic acid metabolism by human
fallopian tubes. 7th Annual Texas Forum of Female Reproduction, May 3-4, 2001, Houston,
TX.
67.
Tumbusch KJ, Goldsby J, Arbab F, Matijevic-Aleksic N, Huang J-C. The expression of
prostaglandin H synthase-2 and the profile of arachidonic acid metabolism by human
fallopian tubes (P-466). 57th Annual Meeting of the American Society for Reproductive
Medicine, Orlando, FL, October 20-25, 2001. Fertil Steril. 76 (3S-suppl):S267-268
68.
Aleksic N, Ahn C, Juneja H, Boerwinkle E, Ballantyne C, Wu KK. Effect of interaction of
plasma soluble thrombomodulin (sTM) and soluble intercellular adhesion molecule-1
(sICAM-1) on predicting risk of incident coronary heart disease (CHD): The ARIC Study.
XVIII Congress of the International Society on Thrombosis and Hemostasis, Paris, France,
July 6-12, 2001. Thromb Haemost Suppl.2001.
69.
Aleksic N, Folsom AR, Cushman M, Heckbert SR, Tsai M, Wu KK. Soluble plasma
thrombomodulin (sTM), TM genotype, and risk of venous thromboembolism: The
Nena Matijevic, PhD
Page 12
Longitudinal Investigation of Thromboembolism Etiology (LITE) Study. XVIII Congress of
the International Society on Thrombosis and Hemostasis, Paris, France, July 6-12, 2001.
Thromb Haemost Suppl. 2001
70.
Folsom AR, Cushman M, Tsai MY, Aleksic N, Heckbert SR, Boland LL, Tsai AW, Yanez
ND, Rosamond WD. Prospective study of venous thromboembolism in relation to factor V
Leiden and related factors: The Longitudinal Investigation of Thromboembolism Etiology
(LITE) Study. XVIII Congress of the International Society on Thrombosis and Hemostasis,
Paris, France, July 6-12, 2001. Thromb Haemost Suppl. 2001.
71.
Tsai A, Cushman M, Tracy RP, Heckbert SR, McGovern P, Aleksic N, Rosamond WD,
Folsom AR. A prospective study of factor VIIIc and von Willebrand factor in relation to
venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology
(LITE) Study. XVIII Congress of the International Society on Thrombosis and Hemostasis,
Paris, France, July 6-12, 2001. Thromb Haemost Suppl.2001
72.
Cushman M, Folsom AR, Wang L, Heckbert SR, White R, Aleksic N, Tsai MY, Tracy RP.
Concentration of Thrombin Activable Fibrinolysis Inhibitor (TAFI), a polymorphism of the
TAFI gene, and the risk of venous thrombosis in a prospective study: The Longitudinal
Investigation of Thromboembolism Etiology (LITE) Study. XVIII Congress of the
International Society on Thrombosis and Hemostasis, Paris, France, July 6-12, 2001.
Thromb Haemost Suppl. 2001
73.
Cushman M, Folsom AR, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin
fragment D-dimer and the risk of future venous thrombosis. American Society of
Hematology, 43rd Annual Meeting, December 7-11, 2001, Orlando, Florida. Blood.
98:11:755a. 2001.
74.
Wu KK, Matijevic-Aleksic N, Ahn C, Juneja H, Wang Y-W. A positive interaction between
plasma thrombomodulin and fibrinogen or factor VIII in predicting incident coronary heart
disease. American Society of Hematology, 43rd Annual Meeting, December 7-11, 2001,
Orlando, Florida. Blood. 98:11:790a. 2001.
75.
Matijevic-Aleksic N, Ahn C, Wang W, Juneja H, Wu KK. Differential association of
thrombomodulin A455V polymorphism with risk of incident coronary heart disease (CHD)
and ischemic stroke: The ARIC study. American Society of Hematology, 43rd Annual
Meeting, December 7-11, 2001, Orlando, Florida. Blood. 98:11:790a. 2001.
76.
Huang J-C, Wun W-S A, Goldsby JS, Matijevic-Aleksic N, Wu KK. Prostacyclin enhances
embryo hatching. 57th Annual Meeting of the American Society for Reproductive Medicine,
Abstracts. 2002.
77.
Matijevic-Aleksic N, Ahn C, Afshar-Kharghan V, Sweetman R, Lopez JA, Nugent DJ,
Boerwinkle E, Wu KK. Coexistence of multiple hemostatic genetic risk factors does not
increase risk of coronary heart disease. XIXth Congress of the International Society on
Nena Matijevic, PhD
Page 13
Thrombosis and Hemostasis, Birmingham, UK, July 12-18. J Thromb Haemost. 1: Suppl 1.
OS239. 2003.
78.
Matijevic N, Radovancevic R, Bracey A, Radovancevic B, Gregoric I, Frazier O. Platelet
and monocyte activation in patients undergoing circulatory support with left ventricular
assist devices (LVAD). XXIst Congress of the International Society on Thrombosis and
Haemostasis, Geneva, Switzerland, July 6-12 2007, J Thromb Haemost 2007; 5, Suppl 2; PW-369.
79.
Matijevic N, Bracey AW, Radovancevic B, Radovancevic R, Gregoric ID, Frazier OH.
Increased leukocyte-platelet interactions associated with high risk heart surgery. 12th
Congress of the European Hematology Association, Vienna 9 June 2007, Book of abstracts:
1596.
80.
Bracey AW, Radovancevic R, Matijevic N, Radovancevic B, Carranza S, Gregoric I,
Frazier OH. Transfusion rates and platelet activation in patients undergoing high risk cardiac
surgery. 12th Congress of the European Hematology Association, Vienna 9 June 2007, Book
of abstracts.
81.
Radovancevic R, Radovancevic B, Bracey A, Matijevic N, Carranza S, Gregoric I, Frazier
OH. Effect of platelet activation on bleeding and transfusion rates in patients undergoing
high risk cardiac surgery. Vox Sang 2007: 93 (Suppl 1):S12-3.
82.
Matijevic N, Catellier D, Wu KK, Heiss G, Folsom AR. Association of monocyte and
platelet markers with peripheral arterial disease: ARIC Carotid MRI Study. 48th
Cardiovascular Disease Epidemiology and Prevention Annual Conference, Colorado
Springs, CO, March 11-15, 2008. Circulation Vol 117, No 11 March 18, 2008, Abstract
p200, page e252
83.
Yamagishi K, Aleksic N, Hannan P, Juneja H, Folsom AR. Coagulation factors II, V, IX, X,
XI, XII, plasminogen and α-2 antiplasmin and risk of coronary heart disease: a case-cohort
study in ARIC. 48th Cardiovascular Disease Epidemiology and Prevention Annual
Conference, Colorado Springs, CO, March 11-15, 2008. Circulation Vol 117, No 11 March
18, 2008.
84.
Aleksic N, Catellier D, Wu KK, Heiss G, Folsom AR. Monocyte and platelet markers in
peripheral arterial disease (PAD): ARIC Carotid MRI study. 20th International Congress on
Thrombosis, Athens, Greece, June 25-28, 2008. Pathophysiol Haemost Thromb 36 (suppl 1)
(2007-08), p068, A41.
85.
Matijevic N, Wang W, Pati S, Kozar R, Conyers J, and Holcomb JB. Phenotypic
assessment of cellular microparticles in fresh frozen plasma during storage. 32d Annual
Conference on Shock, San Antonio, TX. June 6-9, 2009.
86.
Holcomb J, Gerber M, Kozar R, Parthasarthy R, Matijevic N, Doursout MF, Ko T,
Hartwell B, Conyers J and Pati S. Protective effects of plasma (FFP) on pulmonary and
Nena Matijevic, PhD
Page 14
lymphatic endothelial permeability diminish between day 0 through day 5 after thaw. 32nd
Annual Conference on Shock, San Antonio, TX. June 6-9, 2009.
87.
Doursout MF, Liang YY, Pati S, Matijevic N, Uray K, Holcomb JB: Role of the NF-кB
pathway in rats subjected to moderate hemorrhage, FASEB J April 22, 2009 23:LB3802009.
88.
Matijevic N, Dong JF, Hartwell E, Pati S, Holcomb JB. The protective effects of fresh
thawed plasma (FFP) on endothelial permeability are correlated with changes in
thrombospondin-1 microparticles. XXII Congress of the ISTH, Boston July 11-16, 2009. J
Thromb Haemost Vol 7, Supplement 2. PP-MO-767.
89.
Matijevic N, Wu KK, Howard AG, Wasserman B, Wang W, Folsom AR, Sharrett R.
Association of blood cellular markers with carotid plaque size and composition. XXII
Congress of the ISTH, Boston, MA, July 11-16, 2009. J Thromb Haemost Vol 7,
Supplement 2. PP-WE-819.
90.
Nettleton JA, Matijevic N, Follis JL, Folsom AR, and Boerwinkle E. Dietary Patterns and
Flow Cytometry-Measured Biomarkers of Inflammation and Cellular Activation. Joint
Conference - 50th Cardiovascular Disease Epidemiology and Prevention - and - Nutrition,
Physical Activity, and Metabolism, San Francisco, March2010
91.
Kucharska-Newton A, Monda K, Campbell S, Wagenknecht L, Boerwinkle E, Wasserman
B, Aleksic-Matijevic N, Heiss G. Markers of Platelet Activation and Carotid Artery Plaque
Morphology: The Atherosclerosis Risk in Communities (ARIC) Study, AHA 2010
92.
Kucharska-Newton AM, Monda KL, Avery CL, Aleksic-Matijevic N, Folsom AR.
Longitudinal predictors of in vivo platelet activation: The Atherosclerosis Risk in
Communities (ARIC) Carotid MRI Study, AHA 2010
93.
Wang W, Holcomb JB, Kostousov V, Matijevic N. Diminished hemostatic potential of
thawed plasma measured by two novel assays. Shock, vol 33, suppl 1, abstract 55, p 29,
2010. 33th Annual Conference on Shock, Portland, OR, June12-15.
94.
Kostousov V, Matijevic N, Holcomb JB. Deficiency of protein C inhibitor activity in liquid
plasma stored at 4C for 5 days. Shock, vol 33, suppl 1, abstract 58, p 30, 2010. 33th Annual
Conference on Shock, Portland, OR, June12-15.
95.
Matijevic N, Wang W Y-W, Kozar R, Gonzales E, Holcomb JB. Low levels of platelet
microparticles correlate with poor outcomes in shock patients. Shock, vol 33, suppl 1,
abstract 106, p45, 2010. 33th Annual Conference on Shock, Portland, OR, June12-15.
96.
Alrehani N, Matijevic N, Doursout MF, Dong JF, Cruz MA, Holcomb JB, Vinod V.
Regulation of ptotein phosphatase 2B activity and the exocytosis of von Willebrand factor in
hemorrhagic shock. Shock, vol 33, suppl 1, abstract 118, p49, 2010. 33th Annual
Conference on Shock, Portland, OR, June12-15.
Nena Matijevic, PhD
Page 15
97.
Holcomb JB, Rahbar MH, Del Junco DJ, Zhang J, Fox EE, Matijevic N, Cotton BA, Cohen
MJ, Schreiber MA and the PROMMTT Investigators. Initial Report from PROMMTT: The
DoD Sponsored Prospective, Observational, Multi-Center Massive Transfusion Study.
Advanced Technology Applications for Combat Casualty Care (ATACCC) meeting, St
Petersburg, FL, Aug 2010
98.
Matijevic N, Wang Y-W W, Kostousov V, Letourneau P, and Holcomb JB. Multiple levels
of degradation diminish aged plasma’s hemostatic potential. 69th Meeting of the American
Association for the Surgery of trauma (AAST) 2010, Boston, MA, September 23-25.
99.
Letourneau P, McManus M, Sowards K, Wang W, Pati S, Matijevic N, Wade C, Holcomb
J. Aged Plasma Transfusion Increases Mortality in Rat Model of Uncontrolled Hemorrhage.
Western Trauma Association (WEST), Big Sky, Montana, Feb26-March1, 2011
100.
Matijevic N, Kostousov V, Wang YWW, Wade CE, Holcomb JB. Hemostatically distinct
FFPs equally improve abnormal TEG variables in an in vitro dilutional coagulopathy model.
34th Annual Conference on Shock, Norfolk, VA, June11-14, 2011; Shock vol35, suppl1,
2011
101.
Kostousov V, Matijevic N, Wang YWW, Holcomb JB, Cotton B, Wade CE.
Hyperfibrinolytic TEG pattern in diluted blood is provoked by tissue factor. 34th Annual
Conference on Shock, Norfolk, VA, June11-14, 2011; Shock vol35, suppl1, 2011
102.
Pawelczyk NS, Salsbury JR, Baer L, Wang Y, Matijevic N, Letourneau PA, Holcomb JB,
Wade CE. Blood loss after hemodilution and uncontrolled hemorrhage is a function of preinjury MAP and not dilutional coagulopathy. 34th Annual Conference on Shock, Norfolk,
VA, June11-14, 2011; Shock vol35, suppl1, 2011.
103.
Huby MP, Pawelczyk NS, Salsbury JR, Baer L, Wang Y, Matijevic N, Letourneau PA,
Holcomb JB, Wade CE. Blood loss after hemodilution and uncontrolled hemorrhage is a
function of pre-injury MAP and not dilutional coagulopathy. Advanced Technology
Applications for Combat Casualty Care (ATACCC) meeting, Fort Lauderdale, FL, Aug 1518, 2011.
104.
Matijevic N, Kostousov V, Wang Y-W W, Wade CE, Cotton BA, Holcomb JB. The
prevalence of thrombogram-based APC resistant phenotypes among FFP donors. Advanced
Technology Applications for Combat Casualty Care (ATACCC) meeting, Fort Lauderdale,
FL, Aug 15-18, 2011.
105.
Radwan ZA, Bai Y, Matijevic N, del Junco DJ, McCarthy JJ, Wade CE, Holcomb JB,
Cotton BA. An emergency department thawed plasma protocol decreases blood component
utilization and improves survival in severely injured patients. Advanced Technology
Applications for Combat Casualty Care (ATACCC) meeting, Fort Lauderdale, FL, Aug 1518, 2011.
Nena Matijevic, PhD
Page 16
106.
Holcomb JB and the PROMMTT study investigators: Initial report from PROMMTT: The
Prospective, Observational, Multi-Center Massive Transfusion Study. Advanced
Technology Applications for Combat Casualty Care (ATACCC) meeting, Fort Lauderdale,
FL, Aug 15-18, 2011.
107.
Wade C, Holcomb JB, Eastridge BJ, Jones J, Del Junco DJ, Rahbar MH and the
PROMMTT investigators. In-hospital mortality of civilian and military casualties receiving
a blood transfusion. Advanced Technology Applications for Combat Casualty Care
(ATACCC) meeting, Fort Lauderdale, FL, Aug 15-18, 2011.
108.
Matijevic N, Kostousov V, Wang Y-W W, Wade CE, Cotton BA, Holcomb JB. The
prevalence of thrombogram-based APC resistant phenotypes among FFP donors. 70th
Annual Meeting of the American Association for the Surgery of Trauma and Clinical
Congress of Acute Care Surgery, Chicago, IL, September 14-17, 2011.
109.
Cotton BA, Radwan ZA, Matijevic N, Pivalizza E, Podbielski J, Kozar RA, Wade CE,
Holcomb JB. Admission rapid thromboelastography (rTEG) predicts development of
pulmonary embolism in trauma patients. 70th Annual Meeting of the American Association
for the Surgery of Trauma and Clinical Congress of Acute Care Surgery, Chicago, IL,
September 14-17, 2011.
110.
Radwan ZA, Bai Y, Matijevic N, del Junco DJ, McCarthy JJ, Wade CE, Holcomb JB,
Cotton BA. An emergency department thawed plasma protocol decreases blood component
utilization and improves survival in severely injured patients. 70th Annual Meeting of the
American Association for the Surgery of Trauma and Clinical Congress of Acute Care
Surgery, Chicago, IL, September 14-17, 2011.
111.
Matijevic N, Kostousov V, Wang Y-WW, Hartwell E, Holcomb JB. Higher Hemostatic
Potential in the Presence of the Activated Protein C in FP24 Compared to FFP, Annual
Meeting of the American Association of Blood Banks (AABB), October 22-25, 2011, San
Diego, CA.
112.
Sixta S, Hatch Q, Matijevic N, Wade CE, Holcomb JB, Cotton B. Mechanistic
Determinants of the Acute Coagulopathy of Trauma (ACoT) in Patients undergoing
Emergent laparotomy. 53rd Annual Meeting of the American Society of Hematology,
December 10-13, 2011, San Diego, CA, Blood 2011;118:3319.
113.
Cotton BA, Matijevic N, Minei K, Kostousov V, Radwan ZA, Pivalizza E, Wade CE,
Holcomb JB. Hyperfibrinolysis on admission is an uncommon but highly lethal event
associated with shock and prehospital crystalloid administration. 25th Annual Scientific
Assembly, Eastern Association for the Surgery of Trauma (EAST), January 10-14, 2012,
Lake Buena Vista, FL.
114.
Matijevic, N., Kostousov, V., Wang, Y-W.W., Wade, C.E., Holcomb, J.B., and Cotton,
B.A.: Low dose of tranexamic acid reverses hyperfibrinolytic TEG in an in vitro traumatic
Nena Matijevic, PhD
Page 17
coagulopathy model. 7th Congress of the International Federation of Shock Societies and
35th Annual Congress on Shock, Jun 9-13, 2012, Miami Beach, FL.
115.
Matijevic, N., Wang, Y-W., Cotton, B.A., Hartwell, E., Barbeau, J., and Holcomb, J.B.:
Superior hemostatic profiles of never frozen liquid plasma (LQP) compared to thawed fresh
frozen plasma (TP). Annual Meeting of the American Association for Surgery of Trauma
and Clinical Congress of Acute Care Surgery (AAST), September 9-12, 2012, Kauai, HI.
116.
Matijevic, N., Wang, Y-W., Holcomb, .JB., Cotton, B.A., Wade, C.E., Schreiber, M.A.,
Muskat, P., Myers, J.G., and Cohen, M.J., on behalf of the PROMMTT study group:
Cellular profiles following major trauma: the PROMMTT study. PROMMTT Symposium,
September 11, 2012, Kauai, HI.
117.
Cohen, M.J., Kutcher, M., Redick, B., Nelson, M., Call, M., Knudson, M, Schreiber,
M.A., Bulger, E.M., Muskat, P., Alarcon, L.H., Myers, J.G., Rahbar, M.H., Brasel, K.J.,
Phelan, H.A., del Junco, D.J., Fox, E.E, Wade, C.E., Holcomb, J.B, Cotton, B.A., and
Matijevic, N., on behalf of the PROMMTT study group.: Clinical and mechanistic drivers
of acute traumatic coagulopathy. PROMMTT Symposium, September 11, 2012, Kauai, HI.
118.
Fox EE, Bulger EM, Dickerson AS, del Junco DJ, Klotz P, Podbielski J, Matijevic N,
Brasel KJ, Holcomb JB, Schreiber MA, Cotton BA, Phelan HA, Cohen MJ, Myers JG,
Alarcon LH, Muskat P, Wade CE, Rahbar MH, on behalf of the PROMMTT Study Group.
Waiver of consent in non-interventional, observational emergency research: the PROMMTT
experience. PROMMTT Symposium, September 11, 2012, Kauai, HI.
119.
Matijevic, N., Wang, W., Hartwell, E., Cotton, B., Wade, C.E., Barbeau, J., and Holcomb,
J.B.: Clotting properties of never frozen liquid plasma during 26 days of cold storage.
Annual Meeting of the American Association of Blood Banks (AABB), October 6-9, 2012,
Boston, MA.
120.
Goodman MD, Farley DL, Cardenas JC, Pommerening M Podbielski J, Matijevic N, Wade
CE, Holcomb JB, Cotton BA. Thrombelastography velocity curve values more accurately
predict clinically significant fibrinolysis. Surgical Forum of the American College of
Surgeon’s 99th Clinical Congress, Washington, D.C., 2013.
121.
CardenasJ, Wang W, Baer L, Matijevic N, Cotton BA, Holcomb JB, Wade CE. Autologous
Cleavage of the GPIbα Receptor Promotes Platelet Dysfunction Following Trauma.
Thrombosis and Hemostasis Summit of North America, Chicago, IL, April 2013.
122.
Matijevic, N., Wang, Y-W., Holcomb, J.B., Cotton, B.A., Wade, C.E., Schreiber, M.A.,
Muskat, P., Myers, J.G., and Cohen, M.J., on behalf of the PROMMTT study group.:
Circulating microparticles and thrombin generation phenotypes in the Prospective
Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with
coagulopathy and survival. XXIV Congress of the ISTH, June 29-July 04, 2013,
Amsterdam, Netherlands.
Nena Matijevic, PhD
Page 18
123.
Cardenas, J., Matijevic, N., Cotton, B., Holcomb, J., and Wade, C.: Contribution of the
plasminogen activation system during hyperfibrinolysis in trauma-induced coagulopathy.
XXIV Congress of the ISTH, June 29-July 04, 2013, Amsterdam, Netherlands.
124.
Cardenas, J.C, Wang, Y-W., Baer, L.A., Matijevic, N., Cotton, B.A., Holcomb, J.B., and
Wade, C.E.: Autologous Cleavage of the GPIbα Receptor Promotes Platelet Dysfunction
Following Trauma. The American Heart Association Resuscitation Science Symposium,
Dallas, TX, November, 2013.
125.
Dua, A, Cao Y, Matijevic N, Wang Y-W, Pati S, Wade CE, Ko TC, Holcomb JB.
Never frozen liquid plasma blocks endothelial permeability as effectively as thawed fresh
frozen plasma. 27th Annuall Scientific Assembly of The Eastern Association for Surgery of
Trauma (EAST), Naples, FL, Jan 2014.
126.
Cardenas, J.C., Baer, L.A., Matijevic, N., Cotton, B.A., Holcomb, J.B., and Wade, C.E.:
Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion
requirements following trauma. The Western Trauma Association, Steamboat Springs, CO,
March, 2014.
127.
Cardenas, J.C., Wang, Y-W., Baer, L.A., Matijevic, N., Cotton, B.A., Holcomb, J.B., and
Wade, C.E.: Role of GPIbα Receptor Shedding in Platelet Dysfunction Following Trauma.
The 7th Symposium on Hemostasis, Chapel Hill, NC, May, 2014.
B.
REFEREED ORIGINAL ARTICLES IN JOURNALS
1.
Matijevic, N., Sisic, I., Korolija, P., and Pendic, B.: Effect of Complamin® on fibrinolysis
and platelet aggregation in elderly. Bilt. Hematol. Transf. 8: 37-43, 1980. PMID: 7337681
2.
Matijevic-Aleksic, N., Petrovic, M., Vidakovic, B., Plecas, V., and Pendic, B.: Platelet
function in patients treated with cytostatics. Bilt. Hematol. Transf. 91-96, 1985.
3.
Pendic, B., and Matijevic-Aleksic, N.: Influence of cytostatics on platelet aggregation in
vitro. Bilt. Hematol. Transf. 15-20, 1985.
4.
Matijevic-Aleksic, N., Petrovic, M., and Plecas, V.: Hemostasis inhibitors in malignant
diseases. Bilt. Hematol. Transf. 47-55, 1987.
5.
Matijevic-Aleksic, N., and Jelic-Ivanovic, Z.: Effect of oral anticoagulant therapy on two
commercial plasma Protein C assays. Biochimica Clinica. 23-26, 1992.
Nena Matijevic, PhD
Page 19
6.
Elezovic, I., Matijevic-Aleksic, N., and Rolovic, Z.: Antiphospholipid syndrome - recurrent
thromboses and spontaneous abortuses as a consequence of antiphospholipid antibodies.
Srp. Arh. Celok. Lek. 179-181, 1994. PMID: 17977423.
7.
Sanduja, S.K., Tsai, A.L., Matijevic-Aleksic, N., and Wu, K.K.: Kinetics of prostacyclin
synthesis in PGHS-1-overexpressed endothelial cells. Am. J. Physiol. 267: C1459-66, 1994.
PMID: 17977423.
8.
Matijevic-Aleksic, N., Sanduja, S.K., Wang, L-H., and Wu, K.K.: Differential expression of
thromboxane A synthase and prostaglandin H synthase in megakaryocytic cell line.
Biochim. Biophys. Acta. 1269: 167-75, 1995. PMID: 7977706.
9.
Matijevic-Aleksic, N., McPhedran, P., and Wu, K.K.: Bleeding disorder due to platelet
prostaglandin H synthase-1 (PGHS-1) deficiency. Br. J. Haematol. 92: 212-7, 1996. PMID:
8562397.
10.
Wang, L-H., Matijevic-Aleksic, N., Hsu, P.Y., Ruan, K.H., Wu, K.K., and Kulmacz, R.J.:
Identification of thromboxane A2 synthase active site residues by molecular modelingguided site-directed mutagenesis. J. Biol. Chem. 271: 19970-5, 1996. PMID: 8702713.
11.
Ghaddar, H.M., Folsom, A.R., Aleksic, N., Hearne, L.B., Chambless, L.E., Morrissey, J.H.,
and Wu, K.K.: Correlation of factor VIIa values with factor VII gene polymorphism, fasting
and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation. 98:
2815-21, 1998. PMID: 9860781.
12.
Folsom, A.R., Rosamond, W.D., Shahar, E., Cooper, L.S., Aleksic, N., Nieto, F.J.,
Rasmussen, M.L., and Wu, K.K.: Prospective study of markers of hemostatic function with
risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study
Investigators. Circulation. 100: 736-42, 1999. PMID: 10449696.
13.
Salomaa, V., Matei, C., Aleksic, N., Sansores-Garcia, L., Folsom, A.R., Juneja, H.,
Chambless, L.E., and Wu, K.K.: Soluble thrombomodulin as a predictor of incident
coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis
Risk in Communities (ARIC) Study: a case-cohort study. Lancet. 353: 1729-34, 1999.
PMID: 10347984.
14.
Wu, K.K., and Aleksic, N.: Platelet glycoprotein polymorphism and risk for coronary heart
disease. Blood Coagul. Fibrinolysis. 10 Suppl 1: S63-5, 1999. PMID: 10070822.
15.
Xu, X.M., Sansores-Garcia, L., Chen, X.M., Matijevic-Aleksic, N., Du, M., and Wu, K.K.:
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium
salicylate. Proc. Natl. Acad. Sci. U S A. 96: 5292-7, 1999. PMID: 10220459. PMCID:
21857.
16.
Aleksic, N., Juneja, H., Folsom, A.R., Ahn, C., Boerwinkle, E., Chambless, L.E. and Wu,
K.K.: Platelet Pl(A2) allele and incidence of coronary heart disease: results from the
Nena Matijevic, PhD
Page 20
Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 102: 1901-5, 2000. PMID:
11034936.
17.
Folsom, A.R., Wu, K.K., Rasmussen, M., Chambless, L.E., Aleksic, N., and Nieto, F.J.:
Determinants of population changes in fibrinogen and factor VII over 6 years: the
Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 20:
601-6, 2000. PMID: 10669661.
18.
Folsom, A.R., Aleksic, N., Park, E., Salomaa, V., Juneja, H., and Wu, K.K.: Prospective
study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in
Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 21: 611-7, 2001. PMID:
11304480.
19.
Folsom, A.R., Aleksic, N., Ahn, C., Boerwinkle, E., and Wu, K.K.: Beta-fibrinogen gene 455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in
Communities (ARIC) Study. Ann. Epidemiol. 11: 166-70, 2001. PMID: 11293402.
20.
Gilroy, D.W., Saunders, M.A., Sansores-Garcia, L., Matijevic-Aleksic, N., and Wu, K.K.:
Cell cycle-dependent expression of cyclooxygenase-2 in human fibroblasts. FASEB J. 15:
288-90, 2001. PMID: 11156939.
21.
Salomaa, V., Matei, C., Aleksic, N., Sansores-Garcia, L., Folsom, A.R., Juneja, H., Park, E.,
and Wu, K.K.: Cross-sectional association of soluble thrombomodulin with mild peripheral
artery disease; the ARIC study. Atherosclerosis Risk in Communities. Atherosclerosis. 157:
309-14, 2001. PMID: 11472730.
22.
Wu, K.K., Aleksic, N., Ahn, C., Boerwinkle, E., Folsom, A.R., and Juneja, H.:
Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation.
103: 1386-9, 2001. PMID: 11245641.
23.
Aleksic, N., Ahn, C., Wang, Y-W., Juneja, H., Folsom, A.R., Boerwinkle, E., and Wu, K.K.:
Factor XIIIA Val34Leu polymorphism does not predict risk of coronary heart disease: The
Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 22:
348-52, 2002. PMID: 11834540.
24.
Arbab, F., Goldsby, J., Matijevic-Aleksic, N., Huang, G., Ruan, K.H. and Huang, J.C.:
Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle. Hum.
Reprod. 17: 3053-9, 2002. PMID: 12456602.
25.
Folsom, A.R., Aleksic, N., Catellier, D., Juneja, H.S., and Wu, K.K.: C-reactive protein and
incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.
Am. Heart J. 144: 233-8, 2002. PMID: 12177639.
26.
Folsom, A.R., Aleksic, N., Wang, L., Cushman, M., Wu, K.K., and White, R.H.: Protein C,
antithrombin, and venous thromboembolism incidence: a prospective population-based
study. Arterioscler. Thromb. Vasc. Biol. 22: 1018-22, 2002. PMID: 12067914.
Nena Matijevic, PhD
Page 21
27.
Folsom, A.R., Cushman, M., Tsai, M.Y., Heckbert, S.R., and Aleksic, N.: Prospective study
of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration,
and incidence of venous thromboembolism. Am. J. Hematol. 71: 285-90, 2002. PMID:
12447958.
28.
Folsom, A.R., Cushman, M., Tsai, M.Y., Aleksic, N., Heckbert, S.R., Boland, L.L., Tsai,
A.W., Yanez, N.D., and Rosamond, W.D.: A prospective study of venous thromboembolism
in relation to factor V Leiden and related factors. Blood. 99: 2720-5, 2002. PMID:
11929758.
29.
Huang, J.C., Arbab, F., Tumbusch, K.J., Goldsby, J.S., Matijevic-Aleksic, N., and Wu,
K.K.: Human fallopian tubes express prostacyclin (PGI) synthase and cyclooxygenases and
synthesize abundant PGI. J. Clin. Endocrinol. Metab. 87: 4361-8, 2002. PMID: 12213900.
30.
Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Tracy, R.P., Aleksic, N., and
Folsom, A.R.: Coagulation factors, inflammation markers, and venous thromboembolism:
the longitudinal investigation of thromboembolism etiology (LITE). Am. J. Med. 113: 63642, 2002. PMID: 12505113.
31.
Aleksic, N., Folsom, A.R., Cushman, M., Heckbert, S.R., Tsai, M.Y., and Wu, K.K.:
Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma
thrombomodulin, and incidence of venous thromboembolism: the LITE Study. J. Thromb
Haemost. 1: 88-94, 2003. PMID: 12871544.
32.
Cushman, M., Folsom, A.R., Wang, L., Aleksic, N., Rosamond, W.D., Tracy, R.P., and
Heckbert, S.R.: Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood.
101: 1243-8, 2003. PMID: 12393393.
33.
Folsom, A.R., Cushman, M., Heckbert, S.R., Rosamond, W.D., and Aleksic, N.: Prospective
study of fibrinolytic markers and venous thromboembolism. J. Clin. Epidemiol. 56: 598603, 2003. PMID: 12873656.
34.
Tsai, A.W., Cushman, M., Tsai, M.Y., Heckbert, S.R., Rosamond, W.D., Aleksic, N.,
Yanez, N.D., Psaty, B.M., and Folsom, A.R.: Serum homocysteine, thermolabile variant of
methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism:
Longitudinal Investigation of Thromboembolism Etiology (LITE). Am. J. Hematol. 72: 192200, 2003. PMID: 12605391.
35.
Wu, K.K., Aleksic, N., Ballantyne, C.M., Ahn, C., Juneja, H., and Boerwinkle, E.:
Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in
predicting risk of coronary heart disease. Circulation. 107: 1729-32, 2003. PMID:
12668515.
Nena Matijevic, PhD
Page 22
36.
Afshar-Kharghan, V., Matijevic-Aleksic, N., Ahn, C., Boerwinkle, E., Wu, K.K., and
Lopez, J.A.: The variable number of tandem repeat polymorphism of platelet glycoprotein
Ibalpha and risk of coronary heart disease. Blood. 103: 963-5, 2004. PMID: 14592833.
37.
Delgado, R.M., 3rd, Nawar, M.A., Zewail, A.M., Kar, B., Vaughn, W.K., Wu, K.K.,
Aleksic, N., Sivasubramanian, N., McKay, K., Mann, D.L., and Willerson, J.T.:
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a
murine model of doxorubicin-induced heart failure. Circulation. 109: 1428-33, 2004. PMID:
15023870.
38.
Huang, J.C., Wun, W.S., Goldsby, J.S., Matijevic-Aleksic, N., and Wu, K.K.:
Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching.
Hum. Reprod. 19: 2900-6, 2004. PMID: 15489241.
39.
Huang, J.C., Goldsby, J.S., Arbab, F., Melhem, Z., Aleksic, N., and Wu, K.K.: Oviduct
prostacyclin functions as a paracrine factor to augment the development of embryos. Hum.
Reprod. 19: 2907-12, 2004. PMID: 15492023.
40.
Liou, J.Y., Aleksic, N., Chen, S.F., Han, T.J., Shyue, S.K., and Wu, K.K.: Mitochondrial
localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human
cancer cells: implication in apoptosis resistance. Exp. Cell Res. 306: 75-84, 2005.
41.
Liou, J.Y., Lee, S., Ghelani, D., Matijevic-Aleksic, N., and Wu, K.K.: Protection of
endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3
upregulation. Arterioscler. Thromb. Vasc. Biol. 26: 1481-7, 2006. PMID: 15878334.
42.
Liou, J.Y., Ellent, D.P., Lee, S., Goldsby, J., Matijevic, N., Huang, J-C., and Wu, K.K.:
Cyclooxygenase-2 derived PGE2 protects mouse embryonic stem cells from apoptosis via
EP2 and AKT. Stem Cells. 25:1096-103, 2007. PMID: 17234991.
43.
Liou, J.Y., Matijevic-Aleksic, N., Lee, S., and Wu, K.K.: Prostacyclin inhibits endothelial
cell XIAP ubiquitination and degradation. J. Cell Physiol. 212:840-848, 2007. PMID:
17450518.
44.
Catellier, D., Aleksic, N., Folsom, A.R., Boerwinkle, E.: Atherosclerosis Risk in
Communities (ARIC) Carotid MRI Flow Cytometry Study of Monocyte and Platelet
Markers: Intraindividual Variability and Reliability. Clin. Chem. 54:1363-71, 2008. PMID:
18515256. PMCID: 2637799.
45.
Aleksic, N., Wang, Y-W., Ahn, C., Juneja, H.S., Folsom, A.R., and Wu, K.K.: Assessment
of coronary heart disease risk by combined analysis of coagulation factors. Atherosclerosis.
198:294-300, 2008. PMID: 18342864. PMCID: 2579959.
46.
Folsom, A.R., Aleksic, N., Sanhueza, A., and Boerwinkle, E.: Risk factor correlates of
platelet and leukocyte markers assessed by flow cytometry in a population-based sample.
Atherosclerosis. 205:272-278, 2009. PMID: 19124123. PMCID: 2700209.
Nena Matijevic, PhD
Page 23
47.
Volcik, K.A., Catellier, D., Folsom, A.R., Matijevic, N., Wasserman, B., and Boerwinkle,
E.: SELP and SELPLG Genetic Variation is Associated with Cell Surface Measures of
PSEL and PSGL-1: The Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.
Clin. Chem. 55:1076-82, 2009. PMID: 19395438.
48.
Radovancevic, R., Matijevic, N., Bracey, A.W., Radovancevic, B., Elayda, M.A., Gregoric,
I.D., and Frazier, O.H.: Increased Monocyte Activation and Leukocyte-Platelet Interactions
during Circulatory Support with Left Ventricular Assist Devices. ASAIO J. 55:459-64,
2009. PMID: 19730003.
49.
Gottesman, R.F., Cummiskey, C., Chambless, L., Wu, K.K., Aleksic, N., Folsom, A.R., and
Sharrett, A.R.: Hemostatic factors and subclinical brain infarction in a community-based
sample: The ARIC study. Cerebrovasc. Dis. 28:589-594, 2009. PMID: 19844099. PMCID:
2914353.
50.
Pati, S., Matijevic, N., Doursout, M-F., Ko, T., Cao, Y., Deng, X., Gonzalez, E., Dong, J-F.,
Kozar, R.A., Hartwell, E., Conyers, J., and Holcomb, J.B.: The Protective Effects of Day 0
Fresh Frozen Plasma (FFP) on Vascular Endothelial Permeability, Coagulation, and
Resuscitation after Hemorrhagic Shock are Time Dependent and Diminish Between Day 0
and Day 5. J. Trauma. 69 Suppl 1:S55-63, 2010. PMID: 20622621. PMCID: 3126659.
51.
Smith, N.L., Chen, M.H., Dehghan, A., Strachan, D.P., Basu, S., Soranzo, N., Hayward, C.,
Rudan, I., Sabater-Lleal, M., Bis, J.C., de Maat, M.P., Rumley, A., Kong, X., Yang, Q.,
Williams, F.M., Vitart, V., Campbell, H., Mälarstig, A., Wiggins, K.L., Van Duijn, C.M.,
McArdle, W.L., Pankow, J.S., Johnson, A.D., Silveira, A., McKnight, B., Uitterlinden, A.G;
Wellcome Trust Case Control Consortium, Aleksic, N., Meigs, J.B., Peters, A., Koenig, W.,
Cushman, M., Kathiresan, S., Rotter, J.I., Bovill, E.G., Hofman, A., Boerwinkle, E., Tofler,
G.H., Peden, J.F., Psaty, B.M., Leebeek, F., Folsom, A.R., Larson, M.G., Spector, T.D.,
Wright, A.F., Wilson, J.F., Hamsten, A., Lumley, T., Witteman, J.C., Tang, W., and
O'Donnell, C.J.: Novel Associations of Multiple Genetic Loci with Plasma Levels of Factor
VII, Factor VIII, and von Willebrand Factor. The CHARGE (Cohorts for Heart and Aging
Research in Genome Epidemiology) Consortium. Circulation. 121:1382-92, 2010. PMID:
20231535. PMCID: 2861278.
52.
Suri, M.F., Yamagishi, K., Aleksic, N., Hannan, P.J., and Folsom, A.R.: Novel Hemostatic
Factor Levels and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities
(ARIC) Study. Cerebrovasc. Dis. 29:497-502, 2010. PMID: 20299790. PMCID: 2865476.
53.
Yamagishi, K., Aleksic, N., Hannah, P.J., and Folsom, A.R. for the ARIC Study
Investigators. Coagulation factors II, V, IX, X, XI, XII, plasminogen and α-2 antiplasmin
and risk of coronary heart disease. J. Atheroscler. Thromb. 17:402-9, 2010. PMID:
20379055. PMCID: 2866762.
54.
Barbalic, M., Dupuis, J., Dehghan, A., Bi, J.C., Hoogeveen, R.C., Schnabel, R.B., Namb, V.,
Bretler, M., Smith, N.L., Peters, A., Lu, C., Tracy, R.P., Aleksic, N., Heeriga, J., Keaney,
Nena Matijevic, PhD
Page 24
J.F.Jr., Rice, K., Li, G.Y., Vasan, R.S., Glazer, N.L., Larson, M.G., Uitterlinden, A.G.,
Yamamoto, J., Durda, P., Haritunians, T., Psaty, B.M., Boerwinkle, E., Hofman, A., Koenig,
W., Jenny, N.S., Witteman, J.C., Ballantyne, C., and Benjamin, E.J.: Large-scale genomic
studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum. Mol. Genet.
19:1863-72, 2010. PMID: 20167578. PMCID: 2850624.
55.
Nettleton, J.A., Matijevic, N., Follis, J.L., Folsom, A.R., and Boerwinkle, E.: Associations
between dietary patterns and flow cytometry-measured biomarkers of inflammation and
cellular activation in the Atherosclerosis Risk in Communities (ARIC) Carotid Artery MRI
Study. Atherosclerosis. 212:260-267, 2010. PMID: 20537646. PMCID: 2933270.
56.
Tang, W., Basu, S., Kong, X., Pankow, J.S., Aleksic, N., Tan, A., Cushman, M.,
Boerwinkle, E., and Folsom, A.R.: Genome-wide association study identifies novel loci for
plasma levels of protein C: the ARIC study. Blood. 116:5032-5036, 2010. PMID: 2082025.
57.
Lacroix, R., Rober, S., Poncelet, P., Kasthuri, R.S., Key, N.S., and Dignat-George, F.; on
behalf of the ISTH SSC Workshop. Standardization of platelet-derived microparticle
enumeration by flow cytometry with calibrated beads: results of the International Society on
Thrombosis and Haemostasis SSC Collaborative workshop.
Collaborators (58) Leyte A, van Schilfgaarde M, Falanga A, Vignoli A, Enjeti A, Lincz L,
Maraveyas A, Madden L, Bonnefoy A, Rivard J, Ben-Zion K, Lopez J, Davizon-Castillo P,
Maurer-Spurej E, Mullier F, Marvin J, Kwaan H, Weiss I, Bosch I, Woda M, Pereira J,
Hidalgo P, Antovic J, Mobarrez F, Ghosh K, Macchi L, Franck G, Perez-Casal M, Huisse
MG, Macey M, Harrison M, Amirkhosravi A, Davila M, Li N, Matijevic N, Wang W,
Harrison P, Boing AN, Büller H, Nieuwland R, Chandler W, Yeung W, Stirling D, Baird S,
Zahra S, Krueger R, Ross R, Thom J, Osanto S, Yuana Y, Martinez-Sales V, Virtudes V,
Proulle V, Latger-Cannard V, De Carvalho M, Susen S, Carraway MS, Charpentier A.
J. Thromb. Haemost. 8:2571-4, 2010. PMID: 20831623.
58.
Matijevic, N., Wang, Y-W.W., Kostousov, V., Wade, C.E., Vijayan, V., and Holcomb, J.B.:
Decline in platelet microparticles contributes to reduced hemostatic potential of stored
plasma. Thromb. Res. 128:35-41, 2011. PMID: 21421259.
59.
Matijevic, N., Kostousov, V., Wang, Y-W.W., Wade, C.E., Wang, W., Letourneau, P.,
Hartwell, E., Kozar, R., Ko, T., and Holcomb, J.B.: Multiple levels of degradation diminish
hemostatic potential of thawed plasma. J. Trauma. 70:71-80, 2011. PMID: 21217484.
60.
Matijevic, N., Wu, K.K., Nidkarni, N., Heiss, G., and Folsom, A.R.: The ARIC Carotid
MRI study of blood cellular markers: an inverse association of monocyte myeloperoxidase
content with peripheral arterial disease. Angiology. 62:237-44, 2011. PMID: 21487219.
61.
Matijevic, N., Wu, K.K., Howard, A.G., Wasserman, B., Wang, W.Y-W., Folsom, A.R.,
and Sharrett, A.R.: Association of blood monocyte and platelet markers with carotid artery
characteristics The Atherosclerosis Risk in Communities Carotid MRI Study. Cerebrovasc.
Dis. 31:552-558, 2011. PMID: 21487219.
Nena Matijevic, PhD
Page 25
62.
Bielinski, S.J., Hall, J.L., Pankow, J.S., Boerwinkle, E., Matijevic-Aleksic, N., He, M.,
Chambless, L., and Folsom, A.R.: Genetic variants in TLR2 and TLR4 are associated with
markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study. Hum.
Genet. 129:655-62, 2011. PMID: 21298466.
63.
Holcomb J.B., Zarzabal, L.A., Michalek, J.E., Kozar, R.A., Spinella, P.C., Perkins, J.G.,
Matijevic, N., Dong, J-F., Pati, S., Wade, C.E.; Trauma Outcomes Group, Holcomb, J.B.,
Wade, C.E., Cotton, B.A., Kozar, R.A., Brasel, K.J., Vercruysse, G.A., MacLeod, J.B.,
Dutton, R.P., Hess, J.R., Duchesne, J.C., McSwain, N.E., Muskat, P.C., Johannigamn, J.A.,
Cryer, H.M., Tillou, A., Cohen, M.J., Pittet, J.F., Knudson, P., DeMoya, M.A., Schreiber,
M.A., Tieu, B.H., Brundage, S.I., Napolitano, L.M., Brunsvold, M.E., Sihler, K.C., Beilman,
G.J., Peitzman, A.B., Zenati, M.S., Sperry, J.L., Alarcon, L.H., Croce, M.A., Minei, J.P.,
Steward, R.M., Cohn, S.M., Michalek, J.E., Bulger, E.M., Nunez, T.C., Ivatury, R.R.,
Meredith, J.W., Miller, P.R., Pomper, G.J., and Marin, B.: Increased platelet:RBC ratios are
associated with improved survival after massive transfusion. J. Trauma. 71(2 Suppl 3):S31828, 2011. PMID: 21814099.
64.
Letourneau, P.A., McManus, M., Sowards, K., Wang, W., Wang, Y-W., Matijevic, N., Pati,
S., Wade, C.E., and Holcomb, J.B.: Aged plasma transfusion increases mortality in a rat
model of uncontrolled hemorrhage. J. Trauma. 71:1115-9, 2011. PMID: 22071917.
65.
Rahbar, M.H., Fox, E.E., Del Junco, D.J., Cotton, B.A., Podbielski, J.M., Matijevic, N.,
Cohen, M.J., Schreiber, M.A., Zhang, J., Mirhaji, P., Duran, S., Reynolds, R.J., BenjaminGarner, R., and Holcomb, J.B.: The PROMMTT Investigators. Coordination and
management of multicenter clinical studies in trauma: Experience from the PRospective
Observational Multicenter Major Trauma Transfusion (PROMMTT) Study. Resuscitation.
83:459-64, 2012. PMID: 22001613.
66.
Kostousov, V., Wang, Y-W.W., Wade, C.E., Holcomb, J.B., Cotton, B.A., and Matijevic,
N.: Hemostatically distinct FFPs equally improve abnormal TEG variables in an in vitro
dilutional coagulopathy model. Thromb Res. 130:429-34, 2012. PMID: 22386721.
67.
Cotton, B.A., Minei, K.M., Radwan, Z.A., Matijevic, N., Pivalizza, E., Podbielski, J.,
Wade, C.E., Kozar, R.A., and Holcomb, J.B.: Admission rapid thromboelastography
predicts development of pulmonary embolism in trauma patients. J Trauma Acute Care
Surg. 72:1470-5, discussion 1475-7, 2012. PMID: 22695409.
68.
Cotton, B.A., Harvin, J.A., Kostousov, V., Minei, K.M., Radwan, Z.A., Schöchl, H., Wade,
C.E., Holcomb, J.B., and Matijevic, N.: Hyperfibrinolysis on admission is an uncommon
but highly lethal event associated with shock and pre-hospital fluid administration. J Trauma
Acute Care Surg. 73:365-70, discussion 370, 2012. PMID: 22846941.
69.
Tang, W., Schwienbacher, C., Lopez, L.M., Ben-Shlomo, Y., Oudot-Mellakh, T., Johnson,
A.D., Samani, N.J., Basu, S., Gögele, M., Davies, G., Lowe, G.D., Tregouet, D.A., Tan, A.,
Pankow, J.S., Tenesa, A., Levy, D., Volpato, C.B., Rumley, A., Gow, A.J., Minelli, C.,
Yarnell, J.W., Porteous, D.J., Starr, J.M., Gallacher, J., Boerwinkle, E., Visscher, P.M.,
Nena Matijevic, PhD
Page 26
Pramstaller, P.P., Cushman, M., Emilsson, V., Plump, A.S., Matijevic, N., Morange, P.E.,
Deary, I.J., Hicks, A.A., and Folsom, A.R.: Genetic Associations for Activated Partial
Thromboplastin Time and Prothrombin Time, their Gene Expression Profiles, and Risk of
Coronary Artery Disease. Am J Hum Genet. 91:152-62, 2012. PMID: 22703881.
70.
Sixta, S., Hatch, Q., Matijevic, N., Wade, C.E., Holcomb, J.B., and Cotton, B.A.:
Mechanistic determinates of the acute coagulopathy of trauma (ACoT) in patients requiring
emergent laparotomy. Intl J Burns Trauma. 2:158-66, 2012. PMID: 23272297.
71.
Huang, J., Sabater-Lleal M, Asselbergs FW, Tregouet D, Shin SY, Ding J, Baumert J,
Oudot-Mellakh T, Folkersen L, Johnson AD, Smith NL, Williams SM, Ikram MA, Kleber
ME, Becker DM, Truong V, Mychaleckyj JC, Tang W, Yang Q, Sennblad B, Moore JH,
Williams FM, Dehghan A, Silbernagel G, Schrijvers EM, Smith S, Karakas M, Tofler GH,
Silveira A, Navis GJ, Lohman K, Chen MH, Peters A, Goel A, Hopewell JC, Chambers JC,
Saleheen D, Lundmark P, Psaty BM, Strawbridge RJ, Boehm BO, Carter AM, Meisinger C,
Peden JF, Bis JC, McKnight B, Öhrvik J, Taylor K, Franzosi MG, Seedorf U, Collins R,
Franco-Cereceda A, Syvänen AC, Goodall AH, Yanek LR, Cushman M, Müller-Nurasyid
M, Folsom AR, Basu S, Matijevic, N., van Gilst WH, Kooner JS, Hofman A, Danesh J,
Clarke R, Meigs JB; DIAGRAM Consortium, Kathiresan S, Reilly MP; CARDIoGRAM
Consortium, Klopp N, Harris TB, Winkelmann BR, Grant PJ, Hillege HL, Watkins H; C4D
Consortium, Spector TD, Becker LC, Tracy RP, März W, Uitterlinden AG, Eriksson P,
Cambien F; CARDIOGENICS Consortium, Morange PE, Koenig W, Soranzo N, van der
Harst P, Liu Y, O'Donnell CJ, Hamsten A. Genome-wide association study for circulating
levels of PAI-1 provides novel insights into its regulation. Blood. 120:4873-81, 2012.
PMID: 22990020.
72.
Holcomb, J.B., Del Junco, D.J., Fox, E.E., Wade, C.E., Cohen, M.J., Schreiber, M.A.,
Alarcon, L.H., Bai, Y., Brasel, K.J., Bulger, E.M., Cotton, B.A., Matijevic, N., Muskat, P.,
Myers, J.G., Phelan, H.A., White, C.E., Zhang, J., and Rahbar, M.H., for the PROMMTT
Study Group: The Prospective, Observational, Multicenter, Major Trauma Transfusion
(PROMMTT) Study: Comparative Effectiveness of a Time-Varying Treatment With
Competing Risks. Arch Surg. 212:1-10, 2012. PMID: 23070371.
73.
Callcut, R.A., Cotton, B.A., Muskat, P., Fox, E.E., Wade, C.E., Holcomb, J.B., Schreiber,
M.A., Rahbar, M.H., Cohen, M.J., Knudson, M.M., Brasel, K.J., Bulger, E.M., Del Junco,
D.J., Myers, J.G., Alarcon, L.H., and Robinson, B.R. PROMMTT Study Group: Defining
when to initiate massive transfusion: a validation study of individual massive transfusion
triggers in PROMMTT patients. J Trauma Acute Care Surg. 74:59-65, 67-8; discussion 667. 2013. PMID: 23271078.
74.
Matijevic, N., Wang, Y.W., Cotton, B.A., Hartwell, E., Barbeau, J.M., Wade, C.E., and
Holcomb, J.B.: Better hemostatic profiles of never-frozen liquid plasma compared with
thawed fresh frozen plasma. J Trauma Acute Care Surg. 74:84-90, 2013. PMID: 23271081.
discussion 90-1. Erratum in: J Trauma Acute Care Surg. 2013, 74:1182.
75.
Kostousov, V., Wang, Y-W., Cotton, B.A., Wade, C.E., Holcomb, J.B., and Matijevic, N.:
Nena Matijevic, PhD
Page 27
Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a
thrombelastography-based, in-vitro, whole-blood model. Blood Coagul Fibrinolysis. 24:48997, 2013. PMID: 23406662.
76.
Radwan, Z.A., Matijevic, N., Podbielski, J., Del Junco, D., McCarthy, J.J., Bai, Y., Wade,
C.E., Holcomb, J.B., and Cotton, B.A.: An Emergency Department Thawed Plasma Protocol
for Severely Injured Patients. JAMA Surg.148:170-175, 2013. PMID: 23426594.
77.
Holcomb, J.B., del Junco, D.J., Fox, E.E., Wade, C.E., Cohen, M.J., Schreiber, M.A.,
Alarcon, L.H., Bai, Y., Brasel, K.J., Bulger, E.M., Cotton, B.A., Matijevic, N., Muskat, P.,
Myers, J.G., Phelan, H.A., White, C.E., Zhang, J., and Rahbar, M.H. PROMMTT Study
Group: The prospective, observational, multicenter, major trauma transfusion (PROMMTT)
study: comparative effectiveness of a time-varying treatment with competing risks. JAMA
Surg. 148:127-36, 2013. PMID: 23560283.
78.
Pawelczyk, N.S., Huby, M.P., Salsbury, J.S., Baer, L.A., Wang, Y-W.W., Matijevic, N.,
Holcomb, J.B., and Wade, C.E.: Association of hemodilution and blood pressure in
uncontrolled bleeding. J Surg Res.184:959-65, 2013. PMID:23608619.
79.
Wade CE, del Junco DJ, Fox EE, Cotton BA, Cohen MJ, Muskat P, Schreiber MA, Rahbar
MH, Sauer RM, Brasel KJ, Bulger EM, Myers JG, Phelan HA, Alarcon LH, Holcomb JB;
PROMMTT Study Group. Do-not-resuscitate orders in trauma patients may bias mortalitybased effect estimates: an evaluation using the PROMMTT study. J Trauma Acute Care
Surg.;75(1 Suppl 1):S89-96, 2013. PMID:23778517.
80.
Rahbar MH, del Junco DJ, Huang H, Ning J, Fox EE, Zhang X, Schreiber MA, Brasel KJ,
Bulger EM, Wade CE, Cotton BA, Phelan HA, Cohen MJ, Myers JG, Alarcon LH, Muskat
P, Holcomb JB; PROMMTT Study Group. A latent class model for defining severe
hemorrhage: experience from the PROMMTT study. J Trauma Acute Care Surg. 75(1 Suppl
1):S82-8, 2013. PMID:23778516.
81.
Fuchs PA, del Junco DJ, Fox EE, Holcomb JB, Rahbar MH, Wade CA, Alarcon LH, Brasel
KJ, Bulger EM, Cohen MJ, Myers JG, Muskat P, Phelan HA, Schreiber MA, Cotton BA;
PROMMTT Study Group. Purposeful variable selection and stratification to impute missing
Focused Assessment with Sonography for Trauma data in trauma research. J Trauma Acute
Care Surg. 75(1 Suppl 1):S75-81, 2013. PMID:23778515.
82.
Trickey AW, Fox EE, del Junco DJ, Ning J, Holcomb JB, Brasel KJ, Cohen MJ, Schreiber
MA, Bulger EM, Phelan HA, Alarcon LH, Myers JG, Muskat P, Cotton BA, Wade CE,
Rahbar MH; PROMMTT Study Group. The impact of missing trauma data on predicting
massive transfusion. J Trauma Acute Care Surg. 75(1 Suppl 1):S68-74, 2013. PMID:
23778514.
83.
Robinson BR, Cotton BA, Pritts TA, Branson R, Holcomb JB, Muskat P, Fox EE, Wade CE,
del Junco DJ, Bulger EM, Cohen MJ, Schreiber MA, Myers JG, Brasel KJ, Phelan HA,
Alarcon LH, Rahbar MH, Callcut RA; PROMMTT study group. Application of the Berlin
Nena Matijevic, PhD
Page 28
definition in PROMMTT patients: the impact of resuscitation on the incidence of hypoxemia
J Trauma Acute Care Surg. 75(1 Suppl 1):S61-7, 2013. PMID:23778513.
84.
Hubbard A, Munoz ID, Decker A, Holcomb JB, Schreiber MA, Bulger EM, Brasel KJ, Fox
EE, del Junco DJ, Wade CE, Rahbar MH, Cotton BA, Phelan HA, Myers JG, Alarcon LH,
Muskat P, Cohen MJ; PROMMTT Study Group. Time-dependent prediction and evaluation
of variable importance using superlearning in high-dimensional clinical data. J Trauma
Acute Care Surg. 75(1 Suppl 1):S53-60, 2013. PMID:23778512.
85.
Barbosa RR, Rowell SE, Fox EE, Holcomb JB, Bulger EM, Phelan HA, Alarcon LH, Myers
JG, Brasel KJ, Muskat P, del Junco DJ, Cotton BA, Wade CE, Rahbar MH, Cohen MJ,
Schreiber MA; PROMMTT Study Group. Increasing time to operation is associated with
decreased survival in patients with a positive FAST examination requiring emergent
laparotomy. J Trauma Acute Care Surg. 75(1 Suppl 1):S48-52, 2013. PMID:23778511.
86.
Cohen MJ, Kutcher M, Redick B, Nelson M, Call M, Knudson MM, Schreiber MA, Bulger
EM, Muskat P, Alarcon LH, Myers JG, Rahbar MH, Brasel KJ, Phelan HA, del Junco DJ,
Fox EE, Wade CE, Holcomb JB, Cotton BA, Matijevic N; PROMMTT Study Group.
Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care
Surg. 75(1 Suppl 1):S40-7, 2013. PMID:23778510.
87.
Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA, del Junco DJ, Bulger EM,
Cohen MJ, Schreiber MA, Myers JG, Brasel KJ, Phelan HA, Alarcon LH, Muskat P, Rahbar
MH; PROMMTT Study Group. Cryoprecipitate use in the PROMMTT study. J Trauma
Acute Care Surg. 75(1 Suppl 1):S31-9, 2013. PMID:23778509.
88.
del Junco DJ, Holcomb JB, Fox EE, Brasel KJ, Phelan HA, Bulger EM, Schreiber MA,
Muskat P, Alarcon LH, Cohen MJ, Cotton BA, Wade CE, Myers JG, Rahbar MH;
PROMMTT Study Group. Resuscitate early with plasma and platelets or balance blood
products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg. 75(1
Suppl 1):S24-30, 2013. PMID:23778507.
89.
Rahbar E, Fox EE, del Junco DJ, Harvin JA, Holcomb JB, Wade CE, Schreiber MA, Rahbar
MH, Bulger EM, Phelan HA, Brasel KJ, Alarcon LH, Myers JG, Cohen MJ, Muskat P,
Cotton BA; PROMMTT Study Group. Early resuscitation intensity as a surrogate for
bleeding severity and early mortality in the PROMMTT study. J Trauma Acute Care Surg.
75(1 Suppl 1):S16-23, 2013. PMID:23778506.
90.
Hampton DA, Fabricant LJ, Differding J, Diggs B, Underwood S, De La Cruz D, Holcomb
JB, Brasel KJ, Cohen MJ, Fox EE, Alarcon LH, Rahbar MH, Phelan HA, Bulger EM,
Muskat P, Myers JG, del Junco DJ, Wade CE, Cotton BA, Schreiber MA; PROMMTT
Study Group. Prehospital intravenous fluid is associated with increased survival in trauma
patients. J Trauma Acute Care Surg. 75(1 Suppl 1):S9-15, 2013. PMID:23778518.
91.
Fox EE, Bulger EM, Dickerson AS, del Junco DJ, Klotz P, Podbielski J, Matijevic N,
Brasel KJ, Holcomb JB, Schreiber MA, Cotton BA, Phelan HA, Cohen MJ, Myers JG,
Nena Matijevic, PhD
Page 29
Alarcon LH, Muskat P, Wade CE, Rahbar MH; PROMMTT Study Group. Waiver of
consent in noninterventional, observational emergency research: the PROMMTT
experience. J Trauma Acute Care Surg. 75(1 Suppl 1):S3-8, 2013. PMID:23778508.
92.
del Junco DJ, Fox EE, Camp EA, Rahbar MH, Holcomb JB; PROMMTT Study Group.
Seven deadly sins in trauma outcomes research: an epidemiologic post mortem for major
causes of bias. J Trauma Acute Care Surg. 75(1 Suppl 1):S97-103, 2013. PMID:23778519.
93.
Holcomb JB, Fox EE, Wade CE; PROMMTT Study Group. The PRospective Observational
Multicenter Major Trauma Transfusion (PROMMTT) study. J Trauma Acute Care Surg.
75(1 Suppl 1):S1-2, 2013. PMID:23778505.
94.
Huang J, Huffman JE, Yamkauchi M, Trompet S, Asselbergs FW, Sabater-Lleal M,
Trégouët DA, Chen WM, Smith NL, Kleber ME, Shin SY, Becker DM, Tang W, Dehghan
A, Johnson AD, Truong V, Folkersen L, Yang Q, Oudot-Mellkah T, Buckley BM, Moore
JH, Williams FM, Campbell H, Silbernagel G, Vitart V, Rudan I, Tofler GH, Navis GJ,
Destefano A, Wright AF, Chen MH, de Craen AJ, Worrall BB, Rudnicka AR, Rumley A,
Bookman EB, Psaty BM, Chen F, Keene KL, Franco OH, Böhm BO, Uitterlinden AG,
Carter AM, Jukema JW, Sattar N, Bis JC, Ikram MA; Cohorts for Heart and Aging Research
in Genome Epidemiology (CHARGE) Consortium Neurology Working Group, Sale MM,
McKnight B, Fornage M, Ford I, Taylor K, Slagboom PE, McArdle WL, Hsu FC, FrancoCereceda A, Goodall AH, Yanek LR, Furie KL, Cushman M, Hofman A, Witteman JC,
Folsom AR, Basu S, Matijevic N, van Gilst WH, Wilson JF, Westendorp RG, Kathiresan S,
Reilly MP; CARDIoGRAM Consortium, Tracy RP, Polasek O, Winkelmann BR, Grant PJ,
Hillege HL, Cambien F, Stott DJ, Lowe GD, Spector TD, Meigs JB, Marz W, Eriksson P,
Becker LC, Morange PE, Soranzo N, Williams SM, Hayward C, van der Harst P, Hamsten
A, Lowenstein CJ, Strachan DP, O'Donnell CJ; CHARGE Consortium Hemostatic Factor
Working Group. Genome-wide association study for circulating tissue plasminogen
activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
Arterioscler Thromb Vasc Biol. 34:1093-101, 2014. PMID:24578379
95.
Karri JV, Cardenas JC, Johansson PI, Matijevic N, Cotton BA, Wade CE, Holcomb JB.
In vitro efficacy of RiaSTAP after rapid reconstitution. J Surg Res. 190:655-61, 2014.
PMID:24602482
96.
Cardenas JC, Matijevic N, Baer LA, Holcomb JB, Cotton BA, Wade CE. Elevated tissue
plasminogen activator and reduced plasminogen activator inhibitor promote
hyperfibrinolysis in trauma patients. Shock: Injury, Inflammation, and Sepsis. 41:514-21,
2014. PMID:24667610
97.
Huby MP, Cardenas JC, Baer LA, Pawelczyk NS, Salsbury JR, Wang YW, Matijevic N,
Holcomb JB, Wade CE. Establishment of methods for performing thrombelastography and
calibrated automated thrombography in rats. Shock: Injury, Inflammation, and Sepsis.
42:27-30, 2014. PMID:24667614.
98.
Cao Y, Dua A, Matijevic N, Wang YW, Pati S, Wade CE, Ko TC, Holcomb JB. Never-
Nena Matijevic, PhD
Page 30
frozen liquid plasma blocks endothelial permeability as effectively as thawed fresh frozen
plasma. J Trauma Acute Care Surg. 77:28-33, 2014. discussion 33. PMID:24977751.
99.
Baraniuk S, Tilley BC, del Junco DJ, Fox EE, van Belle G, Wade CE, Podbielski JM, Beeler
AM, Hess JR, Bulger EM, Schreiber MA, Inaba K, Fabian TC, Kerby JD, Cohen MJ, Miller
CN, Rizoli S, Scalea TM, O'Keeffe T, Brasel KJ, Cotton BA, Muskat P, Holcomb JB;
PROPPR Study Group. Pragmatic Randomized Optimal Platelet and Plasma Ratios
(PROPPR) Trial: Design, rationale and implementation. Injury. 45:1287-95, 2014.
PMID:24996573.
100.
Matijevic N, Wang YW, Wade CE, Holcomb JB, Cotton BA, Schreiber MA, Muskat P, Fox
EE, Del Junco DJ, Cardenas JC, Rahbar MH, Cohen MJ; PROMMTT Study Group. Cellular
microparticle and thrombogram phenotypes in the Prospective Observational Multicenter
Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy. Thromb
Res. 134:652-8, 2014. PMID:25086657.
101.
Cardenas JC, Rahbar E, Pommerening MJ, Baer LA, Matijevic N, Cotton BA, Holcomb JB,
Wade CE. Measuring thrombin generation as a tool for predicting hemostatic potential and
transfusion requirements following trauma. J Trauma Acute Care Surg. 2014 Aug 5. In
press, PMID:25099452
C.
INVITED ARTICLES IN JOURNALS:
1.
Matijevic-Aleksic, N., and Miletic, V.: Platelet aggregation by monomeric and aggregated
immunoglobulins. Yugoslav. Med. Biochem. 8: 3-7, 1989.
2.
Matijevic-Aleksic, N., and Boskovic, D.: Laboratory control of oral anticoagulant therapy
using two different thromboplastins. Yugoslav. Med. Biochem. 11: 55-58, 1992.
3.
Wu, K.K., Matijevic-Aleksic, N. Thrombomodulin: A linker of coagulation and fibrinolysis
and predictor of risk of arterial thrombosis. Ann. Med. 32; Suppl 1: 73-77, 2000. PMID:
11209986.
4.
Matijevic, N., Wu, K.K.: Biochemical characterization of platelet-monocyte interactions by
flow cytometry. New Trends in Hematology II. 231-240, 2002.
5.
Wu, K.K., and Matijevic-Aleksic, N.: Molecular aspects of thrombosis and antithrombotic
drugs. Crit. Rev. Clin. Lab. Sci. 42:249-277, 2005. PMID: 16047540.
6.
Matijevic, N., Wu, K.K.: Hypercoagulable states and strokes. Curr. Atheroscler. Rep.
8:324-9, 2006. PMID: 16822399.
Nena Matijevic, PhD
Page 31
D.
OTHER PROFESSIONAL COMMUNICATIONS:
1. NATIONAL AND INTERNATIONAL SCIENTIFIC PRESENTATIONS:
1.
6th Meeting of Yugoslav Society of Hematology and Transfusiology (Portoroz, Yugoslavia,
1976).
Pendic B, Matijevic N, Plecas V, Dragovic M. Effects of cytostatics commonly used for the
treatment of acute leukemia on platelet aggregation in vitro.
2.
VII Yugoslav Congress of Pharmacy (Ohrid, Yugoslavia, 1976).
Matijevic N, Pendic B, Zdravkovic M, Ivankovic D. The effect of aspirin on platelet
aggregation in vivo and in vitro.
3.
I Yugoslav Congress of Gerontology (Belgrade, Yugoslavia, 1977).
Matijevic N, Sisic I, Korolija P, Pendic B. Estimation of hemostasis in elderly subjects
treated with Complamin®.
4.
XV Internal Meeting of Internists, Symposium “Drugs and Health” (Subotica, Yugoslavia,
1977)
Zdravkovic M, Matijevic N, Ivankovic D, Pendic B, Tubin M, Cvetkovic G. Platelet
aggregation and gastrointestinal complications during the treatment of rheumatic fever with
aspirin.
5.
III Yugoslav Congress of Hematology and Transfusiology (Sarajevo, Yugoslavia, 1978).
Matijevic-Aleksic N, Pajevic M, Milutinovic Dj, Tomasevic R, Pendic B. The influence of
platelet storage and temperature on platelet functions.
Pajevic M, Matijevic N, Jelic S, Djuric D, Pendic B, Plecas V. Investigation of
immunological and hemostatic parameters related to platelets transfusion in patients with
malignant hemopathies.
Pendic B, Matijevic N. Cytostatics and platelet aggregation.
Jelic S, Bojic M, Dragovic M, Miletic V, Matijevic N, Plecas V. Leukemic phase of diffuse
histiocytic lymphoma (Reticulum Cell Sarcoma).
Miletic V, Jelic S, Gligorovic V, Matijevic N, Plecas V. Physicochemical properties and
biologic effects of commercial gamma globulin preparations.
6.
VII Congress International de Pharmacologie (Paris, France, 1978).
Savic S, Zdravkovic M, Najdanovic B, Ivankovic D, Ristic V, Madic R, Dimitrijevic I,
Djordjevic G, Matijevic N. Les effets du Propranolol (Inderal) sur l' hypertension arterielle
chez les malades avec des valeurs elevees de l' activite de la renine plasmatique.
Nena Matijevic, PhD
Page 32
7.
International Symposium on Essential Hypertension (Herceg Novi, Yugoslavia, 1978).
Savic S, Zdravkovic M, Najdanovic B, Ivankovic D, Djordjevic G, Matijevic N. The
activity of plasma rennin and aldosterone in the essential hypertension and the effects of
Propranolol on the former.
8.
VI Yugoslav Symposium of Immunology (Tara, Yugoslavia, 1979).
Matijevic N, Miletic V, Pendic B. Characteristics of platelet aggregation induced by heataggregated immunoglobulins.
9.
II Meeting of Yugoslav Society of Hemostasis and Thrombosis (Belgrade, Yugoslavia,
1979).
Matijevic N, Miletic V, Pendic B. Aggregation of human blood platelets with monomeric
and aggregated immunoglobulins.
Jelic S, Matijevic N, Miletic V. Platelet aggregation in vitro in the presence of mixed IgG
and IgM cryoglobulins.
10.
VII Meeting of Yugoslav Society of Hematology and Blood Transfusion (Split, Yugoslavia,
1980).
Matijevic N, Petrovic M, Vidakovic B, Plecas V, Pendic B. Platelet function in cytostatics
treated patients.
11.
18th International Congress of the Society of Hematology (Montreal, Canada, 1980).
Pendic B, Matijevic N, Dimitrijevic B, Pantic V. Action des agents da la chimiotherapie sur
l’ aggregation plaquettaires in vitro.
12.
Symposium "Current problems in health care of hematologic patients" (Belgrade,
Yugoslavia, 1980).
Milenkovic Lj, Tomasevic R, Djuric D, Radovic M, Matijevic N. Comments on certain
platelet preparation procedures for transfusion.
13.
VI Yugoslav Congress of Clinical Chemistry (Split, Yugoslavia, 1983).
Matijevic-Aleksic N, Pendic B. Clinical use of platelet aggregation studies.
14.
Yugoslav Congress of Endocrinology (Novi Sad, Yugoslavia, 1984).
Pudar-Brankovic G, Matijevic-Aleksic N, Peric Lj, Mijalkovic D, Brankovic S. Platelet
aggregation in patients with diabetes mellitus.
15.
IV Yugoslav Congress of Hematology and Transfusiology (Skoplje, Yugoslavia, 1984).
Matijevic-Aleksic N, Rolovic Z, Pendic B. Platelet function in patients with idiopathic
thrombocytopenic purpura.
16.
Scientific Meeting of the Serbian Academy of Sciences and Arts, Division of Medical
Sciences, "Specific Hypersensitivity of the Body" (Belgrade, Yugoslavia, 1986).
Despotovic N, Paranos S, Matijevic-Aleksic N, Rosic D. Platelet aggregation abnormalities
in patients with elevated IgE.
Nena Matijevic, PhD
Page 33
17.
V Yugoslav Congress of Hematology and Transfusiology (Maribor, Yugoslavia, 1986).
Matijevic-Aleksic N, Petrovic M, Rajic M,Vidakovic B. Antithrombin III in patients with
malignant hemopathies.
18.
V Yugoslav Symposium on Hemostasis and Thrombosis (Novi Sad, Yugoslavia, 1987).
Matijevic-Aleksic N, Rolovic Z. Platelet aggregation in patients with idiopathic
thrombocytopenic purpura.
19.
VII Yugoslav Congress of Clinical Chemistry (Novi Sad, Yugoslavia, 1987).
Matijevic-Aleksic N, Jovic B, Paranos S, Despotovic N. Influence of elevated
concentrations of serum IgE on human platelet aggregation.
20.
VII Yugoslav Congress of Oncology (Novi Sad, Yugoslavia, 1987).
Matijevic-Aleksic N, Petrovic M, Jovic B, Rajic M, Vidakovic B. Hemostasis inhibitors in
patients with malignant hemopathies.
21.
XXIV Meeting of Oncology and Radiology (Belgrade, Yugoslavia, 1987)
Petrovic M, Matijevic-Aleksic N, Plecas V, Radulovic S. Hemostasis abnormalities in
malignant diseases.
22.
II Dalmatian Meeting of Clinical Chemistry (Split, Yugoslavia, 1988).
Matijevic-Aleksic N, Jelic Z, Majkic-Singh N. Protein C and oral anticoagulant therapy.
Starcevic D, Matijevic-Aleksic N, Jelic-Ivanovic Z. C1-esterase inactivator in malignant
diseases.
23.
IX Meeting of Yugoslav Society of Hematology and Transfusiology (Novi Sad, Yugoslavia,
1988).
Matijevic-Aleksic N, Petrovic M, Plecas V, Vidakovic B, Panajotovic-Jovic B.
Comparisons of hemostatic parameters in patients with malignant diseases.
24.
VI Yugoslav Meeting of the Society of Hemostasis and Thrombosis (Ljubljana, Yugoslavia,
1990).
Matijevic N, Elezovic I, Rolovic Z. Plasma levels of thrombin-antithrombin (TAT) complex
in patients with acute leukemia.
Matijevic N, Elezovic I, Rolovic Z. Plasma levels of fibrinogen and fibrin degradation
products in patients with acute leukemia.
Elezovic I, Matijevic N, Rolovic Z. Plasma levels and activities of factor XIII in patients
with acute leukemia.
25.
11th International Congress on Thrombosis (Ljubljana, Yugoslavia, 1990).
Matijevic-Aleksic N, Boskovic D, Rolovic Z. Monitoring of an oral anticoagulant therapy
using two different thromboplastins.
Nena Matijevic, PhD
Page 34
Matijevic-Aleksic N, Jelic-Ivanovic. Functional assay of Protein C in patients on oral
anticoagulant therapy.
26.
6th Yugoslav Congress of Hematology and Transfusiology (Zagreb, Yugoslavia, 1990).
Matijevic-Aleksic N, Elezovic I, Marisavljevic D, Colovic M, Rolovic Z. Thrombinantithrombin III complex in acute leukemia.
Elezovic I, Matijevic N, Boskovic D, Mijovic A, Tomin D, Colovic M, Novak A, Rolovic
Z. Disseminated intravascular coagulation in patients with acute promyelocytic leukemia.
27.
VIII Yugoslav Scientific Meeting of Alergology and Clinical Immunology (Kopaonik,
Yugoslavia, 1990).
Matijevic-Aleksic N, Elezovic I, Rolovic Z, Dimcic Z, Stefanovic Lj. Laboratory
manifestation of a lupus-like anticoagulant: case report.
Matijevic-Aleksic N, Dimcic Z, Rolovic Z. Protein C and Protein S in systemic diseases.
Elezovic I, Matijevic-Aleksic N, Jancic A, Markovic Lj, Bonaci-Nikolic B, Djordjevic S.
Anticardiolipin antibodies in patients with immune thrombocytopenic purpura.
Dimcic Z, Bukulica M, Djordjevic S, Matijevic-Aleksic N, Markovic Lj, Tanurdcic S,
Djuric M. Hemostatic abnormalities in patients with systemic lupus erythematosus
associated with a presence of anticardiolipin antibodies.
Dimcic Z, Bonaci-Nikolic B, Markovic Lj, Matijevic-Aleksic N, Balaban J, Tanurdcic. A
case of cerebral systemic lupus erythematosus associated with anticardiolipin antibodies.
28.
XIII Congress of the International Society on Thrombosis and Haemostasis (Amsterdam,
Netherlands, 1991).
Matijevic-Aleksic N, Elezovic I, Suvajdic N, Rolovic Z. Levels of fibrinopeptide A and
thrombin-antithrombin III complex in patients with acute leukemia.
Elezovic I, Matijevic-Aleksic N, Marisavljevic D, Suvajdic N, Rolovic Z. Fibrinolysis and
fibrinogenolysis in acute leukemia.
29.
12th International Congress on Thrombosis (Florence, Italy, 1992).
Matijevic-Aleksic N, Dulic B, Rolovic Z. Markers of hemostasis activation after total hip
replacement.
30.
International Meeting of Cardiology (Amsterdam, Netherlands, 1992).
Simic N, Avramovic D, Matijevic-Aleksic N, Stevic S, Kalimanovska-Ostric D. Indobufen
treatment of angina pectoris: effects on platelet aggregation.
31.
35th Annual Meeting of the American Society of Hematology (St. Louis, MO, 1993).
Nena Matijevic, PhD
Page 35
Aleksic N M, Sanduja, S K, Long, C, Wu, K K. Coordinate expression of prostaglandin H
synthase and thromboxane A synthase in phorbol-induced differentiation of a
megakaryocyte cell line (MEG-01).
32.
9th International Conference on Prostaglandins and Related Compounds (Florence, Italy,
1994).
Wu, K.K., Sanduja, S.K, Tsai, A.-L., and Matijevic-Aleksic, N. Quantitative analysis of
prostaglandin H synthase (PGHS-1) decay in cells over expressing PGHS-1.
33.
1st Yugoslav Hematology Congress (Belgrade, Yugoslavia, 1994).
Elezovi I, Matijevic-Aleksic N, Boskovic D, Colovic M, Mijovic AS, Tomin D, Mijovic
AM, Suvajdic N, Vidovic A, Rolovic Z. Disorders of hemostasis in acute leukemia.
Elezovic I, Matijevic-Aleksic N, Colovic M, Boskovic D, Mijovic AS, Tomin D, Mijovic
AM, Suvajdic N, Maric A, Rolovic Z. Disseminated intravascular coagulation in acute
leukemia.
34.
36th Annual Meeting of the American Society of Hematology (Nashville, TN, 1994).
Matijevic-Aleksic N, Ghaddar H, McPhedran P, Wu KK. Bleeding disorder due to platelet
cyclooxygenase-1 (COX-1) deficiency.
35.
XV Congress of the International Society on Thrombosis and Haemostasis (Jerusalem,
Israel, 1995).
Elezovic I, Matijevic-Aleksic N, Rolovic Z. Elastase alpha-1 proteinase inhibitor complexes
in acute leukemia.
36.
38th Annual Meeting of the American Society of Hematology (Orlando, FL, 1996).
Matei MC, Aleksic N, Ahn C, Wu KK, Juneja HS. Hemostasis activation markers in sickle
cell disease: association with painful crisis.
37.
X Yugoslav Hematology Days with International Attendance (Niska Banja, Yugoslavia,
1996).
Elezovic I, Pilic Z, Nedeljkovic N, Marisavljevic D, Matijevic-Aleksic N, Miljic P,
Radosevic N, Todorovic-Tirnanic M: Caesare section in a case with Bernard-Suilier
syndrome.
Elezovic I, Matijevic-Aleksic N, Rolovic Z: The role of elastase in coagulation disorders of
acute leukemia patients.
38.
XVI Congress of the International Society on Thrombosis and Haemostasis (Florence, Italy,
1997).
Ghaddar HM, Aleksic N, Hearne LB, Folsom AR, Chambless LE, Morrissey JH, Wu KK.
The ARIC postprandial study: relation of factor VII with factor VII gene polymorphism and
triglyceride levels in carotid atherosclerosis cases and controls.
39.
71st Scientific Session of the American Heart Association (Dallas, Texas, 1998).
Nena Matijevic, PhD
Page 36
Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen M, Wu
KK. Prospective study of markers of hemostatic function, inflammation, and endothelial
function with risk of ischemic stroke.
Salomaa V, Matei MC, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless
LE, Wu KK. Soluble thrombomodulin as a predictor of incident coronary heart disease: The
ARIC study.
40.
40th Annual Meeting of the American Society of Hematology (Miami Beach, FL, 1998)
Aleksic N, Juneja H, Folsom AR, Ahn C, Boerwinkle E, Chambless W, Wu KK.
Prospective study of platelet PlA1/A2 polymorphism, platelet activation and incidence of
coronary heart disease.
41.
XVII Congress of the International Society on Thrombosis and Haemostasis (Washington,
DC, 1999).
Wu KK, Aleksic N, Ahn C, Boerwinkle E, Folsom A, Juneja H. Association of
thrombomodulin 455A/V dimorphism with risk of developing coronary heart disease.
Aleksic N, Ahn C, Boerwinkle E, Juneja H, Folsom AR, Wu KK. Factor XIII V34L
polymorphism and the risk for development of coronary heart disease.
Afshar-Kharghan V, Aleksic N, Ahn C, Boerwinkle E, Wu KK, Lopez JA. Prospective
study of the association of the variable number of tandem repeats (VNTR) polymorphism in
platelet glycoprotein (GP) Ib alpha and incidence of coronary heart disease.
42.
41th Annual Meeting of the American Society of Hematology (New Orleans, LA, 1999).
Wu KK, Matijevic-Aleksic N, Ahn C, Boerwinkle E, Folsom AR, Juneja H.
Thrombomodulin 455A/V dimorphism is a risk factor for developing coronary heart disease
in African Americans but not in Caucasians: The ARIC Study.
43.
40th Annual Conference on Cardiovascular Disease Epidemiology and Prevention (San
Diego, CA, 2000).
Folsom AR, Aleksic N, Salomaa V, Park E, Juneja H, Wu KK. Fibrinolytic variables and
incident CHD in the Atherosclerosis Risk in Communities (ARIC) Study
44.
28th Congress of the International Society of Hematology (Toronto, Canada, 2000).
Elezovic I, Matijevic-Aleksic N, Rolovic Z, Boskovic D, Colovic M. Hypercoagulability in
patients with acute leukemia prior to therapy.
45.
42nd Annual Meeting of the American Society of Hematology (San Francisco, CA, 2000).
Aleksic N, Ahn C, Juneja H, Boerwinkle E, Ballantyne CM, Wu KK. Effect of interaction of
plasma soluble thrombomodulin (sTM) and soluble intercellular adhesion molecule-1
(sICAM-1) on predicting risk of incident coronary heart disease (CHD): The ARIC Study.
46.
7th Annual Texas Forum of Female Reproduction (Houston, TX, 2001).
Nena Matijevic, PhD
Page 37
Tumbusch KJ, Goldsby J, Arbab F, Matijevic-Aleksic N, Huang J-C. The expression of
prostaglandin H synthase-2 and the profile of arachidonic acid metabolism by human
fallopian tubes.
47.
57th Annual Meeting of the American Society for Reproductive Medicine (Orlando, FL,
2001).
Tumbusch KJ, Goldsby J, Arbab F, Matijevic-Aleksic N, Huang J-C. The expression of
prostaglandin H synthase-2 and the profile of arachidonic acid metabolism by human
fallopian tubes (P-466).
48.
XVIII Congress of the International Society on Thrombosis and Haemostasis (Paris, France,
2001).
Aleksic N, Ahn C, Juneja H, Boerwinkle E, Ballantyne C, Wu KK. Effect of interaction of
plasma soluble thrombomodulin (sTM) and soluble intercellular adhesion molecule-1
(sICAM-1) on predicting risk of incident coronary heart disease (CHD): The ARIC Study.
Aleksic N, Folsom AR, Cushman M, Heckbert SR, Tsai M, Wu KK. Soluble plasma
thrombomodulin (sTM), TM genotype, and risk of venous thromboembolism: The
Longitudinal Investigation of Thromboembolism Etiology (LITE) Study.
Folsom AR, Cushman M, Tsai MY, Aleksic N, Heckbert SR, Boland LL, Tsai AW, Yanez
ND, Rosamond WD. Prospective study of venous thromboembolism in relation to factor V
Leiden and related factors: The Longitudinal Investigation of Thromboembolism Etiology
(LITE) Study.
Tsai A, Cushman M, Tracy RP, Heckbert SR, McGovern P, Aleksic N, Rosamond WD,
Folsom AR. A prospective study of factor VIIIc and von Willebrand factor in relation to
venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology
(LITE) Study.
Cushman M, Folsom AR, Wang L, Heckbert SR, White R, Aleksic N, Tsai MY, Tracy RP.
Concentration of Thrombin Activable Fibrinolysis Inhibitor (TAFI), a polymorphism of the
TAFI gene, and the risk of venous thrombosis in a prospective study: The Longitudinal
Investigation of Thromboembolism Etiology (LITE) Study
49.
43rd Annual Meeting of the American Society of Hematology (Orlando, FL, 2001).
Matijevic-Aleksic N, Ahn C, Wang W, Juneja H, Wu KK. Differential association of
thrombomodulin A455V polymorphism with risk of incident coronary heart disease (CHD)
and ischemic stroke: The ARIC study.
Wu KK, Matijevic-Aleksic N, Ahn C, Juneja H, Wang Y-W. A positive interaction between
plasma thrombomodulin and fibrinogen or factor VIII in predicting incident coronary heart
disease.
Cushman M, Folsom AR, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin
fragment D-dimer and the risk of future venous thrombosis.
Nena Matijevic, PhD
Page 38
50.
57th Annual Meeting of the American Society for Reproductive Medicine (Orlando, FL,
2001).
Huang J-C, Wun W-S A, Goldsby JS, Matijevic-Aleksic N, Wu KK. Prostacyclin enhances
embryo hatching.
51.
1st Serbian Congress of Hematology (Belgrade, Serbia, 2002)
Matijevic N, Wu KK. Biochemical characterization of platelet-monocyte interactions by
flow cytometry.
52.
XIX Congress of the International Society on Thrombosis and Hemostasis (Birmingham,
UK, 2003).
Matijevic-Aleksic N, Ahn C, Afshar-Kharghan V, Sweetman R, Lopez JA, Nugent DJ,
Boerwinkle E, Wu KK. Coexistence of multiple hemostatic genetic risk factors does not
increase risk of coronary heart disease.
53.
XXI Congress of the International Society on Thrombosis and Haemostasis (Geneva,
Switzerland, 2007).
N. Matijevic, R. Radovancevic, A. Bracey, B. Radovancevic, I. Gregoric, O. Frazier.
Platelet and monocyte activation in patients undergoing circulatory support with left
ventricular assist devices (LVAD).
54.
XVIIth Regional Congress of the International Society of Blood Transfusion (Madrid,
Spain, 2007).
Radovancevic R, Radovancevic B, Bracey A, Matijevic N, Carranza S, Gregoric I, Frazier
OH. Effect of platelet activation on bleeding and transfusion rates in patients undergoing
high risk cardiac surgery.
55.
12th Congress of the European Hematology Association (Vienna, Austria, 2007).
Matijevic N, Bracey AW, Radovancevic B, Radovancevic R, Gregoric ID, Frazier OH.
Increased leukocyte-platelet interactions associated with high risk heart surgery.
Bracey AW, Radovancevic R, Matijevic N, Radovancevic B, Carranza S, Gregoric I,
Frazier OH. Transfusion rates and platelet activation in patients undergoing high risk cardiac
surgery.
56.
20th International Congress on Thrombosis (Athens, Greece, 2008)
N Aleksic, D Catellier, KK Wu, G Heiss, AR Folsom. Monocyte and platelet markers in
peripheral arterial disease (PAD): ARIC Carotid MRI study.
57.
48th Cardiovascular Disease Epidemiology and Prevention Annual Conference (Colorado
Springs, CO, 2008).
Matijevic N, Catellier D, Wu KK, Heiss G, Folsom AR. Association of monocyte and
platelet markers with peripheral arterial disease: ARIC Carotid MRI Study.
Nena Matijevic, PhD
Page 39
Yamagishi K, Aleksic N, Hannan P, Juneja H, Folsom AR. Coagulation factors II, V, IX, X,
XI, XII, plasminogen and α-2 antiplasmin and risk of coronary heart disease: a case-cohort
study in ARIC .
58.
32nd Annual Conference on Shock (San Antonio, TX, 2009).
N Matijevic, W Wang, S Pati, R Kozar, J Conyers, and J Holcomb. Phenotypic assessment
of cellular microparticles in fresh frozen plasma during storage.
J Holcomb, M Gerber, R Kozar, R Parthasarthy, N Matijevic, MF Doursout, T Ko, B
Hartwell, J Conyers and S Pati. Protective effects of plasma (FFP) on pulmonary and
lymphatic endothelial permeability diminish between day 0 through day 5 after thaw.
59.
Experimental Biology Meeting (New Orleans, LA, 2009)
Doursout MF, Liang YY, Pati S, Matijevic N, Holcomb J.B: Role of the NF-кB pathway in
rats subjected to moderate hemorrhage.
60.
XXII Congress of the International Society on Thrombosis and Haemostasis (Boston, MA,
2009).
Matijevic N, Dong JF, Hartwell E, Pati S, Holcomb JB. The protective effects of fresh
thawed plasma (FFP) on endothelial permeability are correlated with changes in
thrombospondin-1 microparticles.
Matijevic N, Wu KK, Howard AG, Wasserman B, Wang W, Folsom AR, Sharrett R.
Association of blood cellular markers with carotid plaque size and composition.
61.
Joint Conference - 50th Cardiovascular Disease Epidemiology and Prevention - and Nutrition, Physical Activity, and Metabolism (San Francisco, CA, 2010).
Nettleton JA, Matijevic N, Follis JL, Folsom AR, and Boerwinkle E. Dietary Patterns and
Flow Cytometry-Measured Biomarkers of Inflammation and Cellular Activation.
Kucharska-Newton A, Monda K, Campbell S, Wagenknecht L, Boerwinkle E, Wasserman
B, Aleksic-Matijevic N, Heiss G. Markers of Platelet Activation and Carotid Artery Plaque
Morphology: The Atherosclerosis Risk in Communities (ARIC) Study.
Kucharska-Newton A, Monda K, Avery C, Folsom A, Aleksic-Matijevic N: Longitudinal
predictors of levels of in vivo platelet activation markers: The Atherosclerosis Risk in
Communities (ARIC) Carotid MRI Study.
62.
33th Annual Conference on Shock (Portland, OR, 2010)
W Wang, JB Holcomb, V. Kostousov, N. Matijevic. Diminished hemostatic potential of
thawed plasma measured by two novel assays.
V Kostousov, N Matijevic, JB Holcomb. Deficiency of protein C inhibitor activity in liquid
plasma stored at 4ºC for 5 days.
Nena Matijevic, PhD
Page 40
N Matijevic, W. Y-W Wang, R Kozar, E Gonzales, JB Holcomb. Low levels of platelet
microparticles correlate with poor outcomes in shock patients.
Alrehami N, Matijevic N, Doursout MF, Dong JF, Cruz MA, Holcomb JB and Vijayan KV.
Regulation of protein phosphatas 2B activity and the exocytosis of von Willebrand factor in
hemorrhagic shock.
63.
Advanced Technology Applications for Combat Casualty Care (ATACCC) (St.Petersburg,
FL, 2010).
JB Holcomb, MH Rahbar, DJ del Junco, J Zhang, EE Fox, N Matijevic, BA Cotton, MJ
Cohen, MA Schreiber and the PROMMTT Investigators. Initial Report from PROMMTT:
The DoD Sponsored Prospective, Observational, Multi-Center Massive Transfusion Study.
64.
69th Meeting of the American Association for the Surgery of Trauma (Boston, MA, 2010)
Matijevic N, Wang Y-W W, Kostousov V, Letourneau P, and Holcomb JB. Multiple levels
of degradation diminish aged plasma’s hemostatic potential
65.
Western Trauma association (WEST) (Big Sky, Montana, 2011)
Letourneau P, McManus M, Sowards K, Wang W, Pati S, Matijevic N, Wade CE,
Holcomb JB. Aged Plasma Transfusion Increases Mortality in Rat Model of Uncontrolled
Hemorrhage.
66.
34rd Annual Conference on Shock (Norfolk, Virginia, 2011)
Matijevic N, Kostousov V, Wang Y-WW, Wade CE, Holcomb JB. Hemostatically distinct
FFPs equally improve abnormal TEG variables in an in vitro dilutional coagulopathy
model.
Kostousov V, Matijevic N, Wang Y-WW, Holcomb JB, Cotton BA, Wade CE.
Hyperfibrinolytic TEG pattern in diluted blood is provoked by tissue factor.
Pawelczyk NS, Salsbury JR, Baer L, Wang Y, Matijevic N, Letourneau PA, Holcomb JB,
Wade CE. Blood loss after hemodilution and uncontrolled hemorrhage is a function of preinjury MAP and not dilutional coagulopathy.
67.
Conference of the Advanced Technology Applications for Combat Casualty Care
(ATACCC) (Fort Lauderdale, FL, 2011).
Matijevic N, Kostousov V, Wang Y-W W, Wade CE, Cotton BA, Holcomb JB. The
prevalence of thrombogram-based APC resistant phenotypes among FFP donors.
Radwan ZA, Bai Y, Matijevic N, del Junco DJ, McCarthy JJ, Wade CE, HolcombJB ,
Cotton BA. An emergency department thawed plasma protocol decreases blood component
utilization and improves survival in severely injured patients.
Wade C, Holcomb JB, Eastridge BJ, Jones J, Del Junco DJ, Rahbar MH and the
PROMMTT investigators. In-hospital mortality of civilian and military casualties receiving
a blood transfusion.
Nena Matijevic, PhD
Page 41
Holcomb J and the PROMMTT study investigators: Initial report from PROMMTT: The
Prospective, Observational, Multi-Center Massive Transfusion Study.
Huby MP, Pawelczyk NS, Salsbury JR, Baer L, Wang Y, Matijevic N, Letourneau PA,
Holcomb JB, Wade CE. Blood loss after hemodilution and uncontrolled hemorrhage is a
function of pre-injury MAP and not dilutional coagulopathy.
Cotton BA, Kostousov V, Radwan ZA, Pivalizza E, Podbielski J, Matijevic N, Wade CE,
Holcomb JB. Hyperfibrinolysis on admission is an uncommon but highly lethal event
associated with shock and prehospital crystalloid administration.
68.
70th Meeting of the American Association for the Surgery of Trauma (Chicago, IL, 2011).
Matijevic N, Kostousov V, Wang Y-W W, Wade CE, Cotton BA, Holcomb JB. The
prevalence of thrombogram-based APC resistant phenotypes among FFP donors.
Cotton BA, Minei KM, Radwan ZA, Matijevic N, Pivalizza E, Podbielski J, Wade CE
Kozar RA, Holcomb JB. Admission rapid thrombelastography (r-TEG) predicts
development of pulmonary embolism in trauma patients.
Radwan ZA, Bai Y, Matijevic N, del Junco D, McCarthy JJ, Wade CE, Holcomb JB,
Cotton BA. An emergency department thawed plasma protocol decreases blood component
utilization and improves survival in severely injured patients.
69.
American Association of Blood Banks Annual Meeting (San Diego, CA, 2011).
Matijevic N, Kostousov V, Wang Y-WW, Hartwell B, Holcomb JB. Higher Hemostatic
Potential in the Presence of the Activated Protein C in FP24 Compared to FFP.
70.
Annual Meeting of the American Society of Hematology (San Diego, CA, 2011).
Cotton BA, Sixta S, Wade CE, Holcomb JB, Matijevic N. Mechanistics determinants of the
acute coagulopathy of trauma (ACoT) in patients undergoing emergency surgery.
71.
25th Annual Scientific Assembly, Eastern Association for the Surgery of Trauma (EAST),
(Lake Buena Vista, FL, 2012).
Cotton BA, Matijevic N, Minei K, Kostousov V, Radwan ZA, Pivalizza E, Wade CE,
Holcomb JB. Hyperfibrinolysis on admission is an uncommon but highly lethal event
associated with shock and prehospital crystalloid administration.
72.
7th Congress of the International Federation of Shock Societies and 35th Annual Congress
on Shock (Miami Beach, FL, 2012).
Matijevic N, Kostousov V, Wang Y-WW, Wade CE, Holcomb JB, Cotton BA. Low dose of
tranexamic acid reverses hyperfibrinolytic TEG in an in vitro traumatic coagulopathy model.
73.
71st Annual Meeting of the American Association for Surgery of Trauma and Clinical
Congress of Acute Care Surgery (AAST) (Kauai, HI, 2012).
Nena Matijevic, PhD
Page 42
Matijevic N, Wang Y-W, Cotton BA, Hartwell E, Barbeau J, Holcomb JB. Superior
hemostatic profiles of never frozen liquid plasma (LQP) compared to thawed fresh frozen
plasma (TP).
74.
Annual Meeting of the American Association of Blood Banks (AABB), (Boston, MA,
2012).
Matijevic N, Wang W, Hartwell E, Cotton B, Wade CE, Barbeau J, Holcomb JB. Clotting
properties of never frozen liquid plasma during 26 days of cold storage.
75.
Thrombosis and Hemostasis Summit of North America (Chicago, IL, April 2013)
CardenasJ, Wang W, Baer L, Matijevic N, Cotton BA, Holcomb JB, Wade CE. Autologous
Cleavage of the GPIbα Receptor Promotes Platelet Dysfunction Following Trauma
76.
Surgical Forum of the American College of Surgeon’s 99th Clinical Congress (Washington,
D.C., 2013).
Goodman MD, Farley DL, Cardenas JC, Pommerening M Podbielski J, Matijevic N, Wade
CE, Holcomb JB, Cotton BA. Thrombelastography velocity curve values more accurately
predict clinically significant fibrinolysis.
77.
XXIV Congress of the International Society on Thrombosis and Haemostasis (ISTH),
(Amsterdam, Netherlands, 2013).
Matijevic N, Y-W Wang, JB Holcomb, BA Cotton, CE Wade, MA Schreiber, P Muskat, JG
Myers, and MJ Cohen, on behalf of the PROMMTT study group. Circulating microparticles
and thrombin generation in the PROMMTT study: association with coagulopathy and
survival.
Cardenas JC, Matijevic N, Cotton BA, Holcomb JB, Wade CE. Contribution of the
plasminogen activation system during hyperfibrinolysis in trauma-induced coagulopathy.
78.
The American Heart Association Resuscitation Science Symposium (Dallas, TX, 2013).
Cardenas JC, Wang YW, Baer LA, Matijevic N, Cotton BA, Holcomb JB, Wade CE.:
Autologous Cleavage of the GPIbα Receptor Promotes Platelet Dysfunction Following
Trauma.
79.
27th Annuall Scientific Assembly of The Eastern Association for Surgery of Trauma
(EAST), (Naples, FL)
Dua, A, Cao Y, Matijevic N, Wang Y-W, Pati S, Wade CE, Ko TC, Holcomb JB.
Never frozen liquid plasma blocks endothelial permeability as effectively as thawed fresh
frozen plasma.
80.
The Western Trauma Association (Steamboat Springs, CO, 2014).
Cardenas JC, Baer LA, Matijevic N, Cotton BA, Holcomb JB, Wade CE. Measuring
thrombin generation as a tool for predicting hemostatic potential and transfusion
requirements following trauma.
81.
The 7th Symposium on Hemostasis (Chapel Hill, NC, 2014).
Nena Matijevic, PhD
Page 43
Cardenas JC, Wang YW, Baer LA, Matijevic N, Cotton BA, Holcomb JB, Wade CE.: Role
of GPIbα Receptor Shedding in Platelet Dysfunction Following Trauma.
2. NON-REFEREED PUBLICATIONS
1. Zdravkovic M, Matijevic N, Ivankovic D, Pendic B, Tubin M, Cvetkovic G. Platelet
aggregation and gastrointestinal complications during therapy of rheumatic fever by
acetylsalicylic acid. Proc Symp Internists Drugs Health, Subotica, 229-234, 1977.
2. Matijevic-Aleksic N, Pajevic M, Milutinovic Dj, Tomasevic R, Pendic B. The influence of
storage and temperature on some functions of platelet suspensions. Proc III Yug
Hematology and Transfusiology Congress, Sarajevo, 905-909, 1978.
3. Pudar-Brankovic G, Matijevic-Aleksic N, Peric Lj, Mijalkovic D, Brankovic P. Platelet
aggregation in patients with diabetes mellitus. Proc III Yug Endocrinology Congress, Novi
Sad, 547, 1984.
3. OTHER
WORKSHOPS
1. Atherosclerosis Risk in Communities (ARIC) Steering Committee Meetings, National Heart,
Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, once or twice per year, 19962005.
2. “Transagency Coagulopathy in Trauma Workshop”, National Heart, Lung, and Blood
Institute (NHLBI) and Department of Defense (DoD), NIH, Bethesda, MD, April 5-6, 2010.
3. “Acute Trauma Sample Processing from Injury Site”, The Division of Blood Diseases and
Resources (DBDR), National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda,
MD, April 1, 2011
4. Pragmatic Observational Plasma and Platelet Ratio (PROPPR) Investigators Meeting, La
Torreta Lake Resort, Lake Conroe, Montgomery, TX, July 18-20, 2011.
5. Pragmatic Observational Plasma and Platelet Ratio (PROPPR) Investigators Meeting, La
Torreta Lake Resort, Lake Conroe, Montgomery, TX, Jan 18-20, 2012.
6. Pragmatic Observational Plasma and Platelet Ratio (PROPPR) Investigators Meeting,
Houston, TX, Jan 30-31, 2013.
Nena Matijevic, PhD
Page 44
7. Pragmatic Observational Plasma and Platelet Ratio (PROPPR) Investigators Meeting,
Houston, TX, Jan 30-31, 2014.
Nena Matijevic, PhD
Page 45